WO1997009008A1 - Method and apparatus for conformably sealing prostheses within body lumens - Google Patents

Method and apparatus for conformably sealing prostheses within body lumens Download PDF

Info

Publication number
WO1997009008A1
WO1997009008A1 PCT/US1996/014281 US9614281W WO9709008A1 WO 1997009008 A1 WO1997009008 A1 WO 1997009008A1 US 9614281 W US9614281 W US 9614281W WO 9709008 A1 WO9709008 A1 WO 9709008A1
Authority
WO
WIPO (PCT)
Prior art keywords
tubular
sealing layer
prosthesis
body lumen
fluid
Prior art date
Application number
PCT/US1996/014281
Other languages
French (fr)
Inventor
Thomas J. Forgarty
Jay A. Lenker
Brian J. Coy
Allan R. Will
Kirsten Freislinger
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic, Inc. filed Critical Medtronic, Inc.
Priority to AU71547/96A priority Critical patent/AU7154796A/en
Priority to DE69633789T priority patent/DE69633789T2/en
Priority to AT96932961T priority patent/ATE281129T1/en
Priority to EP96932961A priority patent/EP0857040B1/en
Publication of WO1997009008A1 publication Critical patent/WO1997009008A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • A61F2/945Stents retaining their form, i.e. not being deformable, after placement in the predetermined place hardenable, e.g. stents formed in situ
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/077Stent-grafts having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30581Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
    • A61F2002/30583Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0085Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof hardenable in situ, e.g. epoxy resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates generally to methods and apparatus for the endoluminal placement of tubular prostheses, such as grafts, stents, and other structures. More particularly, the present invention relates to the implantation of luminal prostheses in a sealing layer within a body lumen.
  • Vascular aneurysms are the result of abnormal dilation of a blood vessel, usually resulting from disease and/or genetic predisposition which can weaken the arterial wall and allow it to expand.
  • aneurysms can occur in any blood vessel, most occur in the aorta and peripheral arteries, with the majority of aortic aneurysms occurring in the abdominal aorta, usually beginning below the renal arteries and often extending distally into one or both of the iliac arteries.
  • Aortic aneurysms are most commonly treated in open surgical procedures where the diseased vessel segment is bypassed and repaired with an artificial vascular graft. While considered to be an effective surgical technique, particularly considering the alternative of a usually fatal ruptured abdominal aortic aneurysm, conventional vascular graft surgery suffers from a number of disadvantages.
  • the surgical procedure is complex and requires experienced surgeons and well-equipped surgical facilities. Even with the best surgeons and equipment, however, the patient ⁇ being treated frequently are elderly and weakened from cardiovascular and other diseases, reducing the number of eligible patients.
  • conventional aneurysm repair surgery performed prior to rupture has a relatively high mortality rate, usually from 2% to 10%. Morbidity related to the conventional surgery includes myocardial infarction, renal failure, impotence, paralysis, and other conditions. Additionally, even with successful surgery, recovery can take several weeks and often requires a lengthy hospital stay.
  • endovascular graft placement procedures for the treatment of aneurysms have been proposed.
  • endovascular procedures will deliver a radially compressed graft intravascularly to the aneurysm.
  • the graft is then expanded in si tu, either by releasing a self-expanding graft or by internally expanding a malleable graft (e.g. using a balloon catheter) to protect the aneurysm.
  • the vascular graft will comprise both a frame and a liner, where the frame provides the necessary mechanical support and the liner provides the necessary blood barrier.
  • vascular grafts While highly promising, the endovascular placement of vascular grafts is problematic in several respects. In contrast to surgically implanted grafts, which are sutured in place, endovascularly placed grafts can be difficult to anchor and position. Reliance on the outward spring-force of a self-expanding graft is not always sufficient. Malleable grafts, in contrast, may be easier to initially anchor but may be less able to expand and contract with the blood vessel during the continuous pulse of the patient. While the use of hooks or barbs for anchoring grafts into the blood vessel wall has been proposed, such devices can be traumatic and can loosen from the blood vessel wall over time.
  • a graft structure 10 implanted within the region of an aneurysm A in a blood vessel BV is illustrated. While the graft 10 may be adequately anchored on each side of the aneurysm A, as illustrated in Fig. 1, over time the inner surface of the blood vessel lumen can partially separate from the outer surface of the graft 10, as illustrated in Figs. 2 and 3. Such separations S can allow bypass blood flow into the region of the aneurysm A.
  • intraluminal prostheses and methods for their implantation which can overcome at least some of the difficulties described above.
  • intraluminal prostheses and methods for their implantation which would provide a generally fluid tight seal circumscribing at least one end of the prosthesis, and preferably both ends or the entire length of the prosthesis, to prevent bypass blood or other fluid flow into the interstitial region between the inner wall of the body lumen and the outer surface of the prosthesis.
  • such improved prostheses and methods for their implantation would provide for sealing of the prosthesis which would resist separating from the intraluminal wall in order to prevent such bypass flow in a long-term or permanent fashion after implantation of the prosthesis.
  • a contact adhesive such as cyanoacrylate
  • the use of autologous fibrin glue for sealing porous, fabric grafts prior to open surgical implantation is described in Kjaergard and Weis-Fogh (1994) Card. Surg. 2:45-46.
  • a tubular prosthesis having an annular cavity for receiving a plastic material to enlarge and anchor the prosthesis within a blood vessel is described in U.S. Patent No. 5,156,620.
  • a tubular prosthesis having inflatable cuffs on each end is described in U.S. Patent No. 3,991,767.
  • a tubular prosthesis having everted cuffs for receiving sutures is described in U.S. Patent No. 4,728,328.
  • a tubular stent having hook-like projections over its outer surface is described in U.S. Patent No. 5,167,614.
  • a tubular stent having a plurality of self-locking fingers extending outward from its outer surface is described in U.s. Patent No. 5,344,426.
  • a fluid delivery catheter comprising concentric lumens in a balloon structure is described in U.S. Patent No. 5,295,962.
  • a vascular prosthesis comprising two porous concentrically associated tubes with a helical spring enclosed therebetween is disclosed in U.S. Patent No. 4,130,904.
  • a vascular prosthesis comprising a multilaminar tubular member is disclosed in U.S. Patent No. 5,354,329.
  • Microporous materials suitable for the fabrication of prosthetic devices are described in U.S. Patent Nos. 3,890,107 and 5,348,788.
  • the present invention provides methods and apparatus for the transluminal positioning of tubular prostheses at a target location within a body lumen.
  • the tubular prostheses are suitable for a wide variety of therapeutic uses, including stenting of the ureter, urethra, biliary tract, and the like.
  • the devices and methods will also find use in the creation of temporary or long-term lumens, such a ⁇ the formation of fistulas.
  • the present invention will find its greatest use, however, in the placement of endovascular grafts into blood vessels for the treatment of abdominal and other aneurysms, vascular stenoses, and the like.
  • a tubular prosthesis is delivered to the target site within the body lumen in a radially compressed configuration and is expanded in si tu at the target location so that an exterior ⁇ urface of the prosthesis engages an inner wall of the body lumen over an interface region therebetween.
  • Radial expansion of the prosthesis may be effected in any conventional manner, including the use of a balloon catheter for expanding malleable prostheses, the release of compressed, self-expanding prosthese ⁇ from suitable delivery catheters, and the like.
  • the present invention particularly provides for expansion of the prosthese ⁇ into a sealing layer which is disposed in or over at least a portion of the interface region.
  • the sealing layer may be disposed within substantially the entire interface region, or may be disposed over one or more discrete, circumferential bands within the interface region.
  • the sealing layer will be disposed at least at each end of the tubular prosthesis in order to provide a barrier against the bypass leakage of fluid into portions of the interface region therebetween.
  • the ⁇ ealing layer will occupy ⁇ ub ⁇ tantially the entire interface region.
  • the sealing layer may be composed of virtually any material which is biocompatable and capable of conforming to the interface region between the outer wall of the tubular prosthe ⁇ is and the inner wall of the body lumen.
  • Exemplary materials include gels, foams, adhesives, biological polymers, compliant sleeve ⁇ , sponges, porous matrices and meshes, and the like.
  • the material ⁇ are initially present on the prosthesis or delivered in a fluid or semi-solid ⁇ tate to the interface region, and thereafter cured or hardened to achieve the final, de ⁇ ired geometry.
  • the sealing layer may be composed of materials which expand in si tu in order to fully conform to the geometry of the interface region, e.g. including materials ⁇ uch as hydrophilic gels, hydrophilic foams, and the like.
  • An exemplary material for the sealing layer comprises a microporous mesh, particularly composed of silicone rubber and similar materials .
  • the sealing layer may be initially formed or disposed over at least a portion of the exterior surface of the tubular prosthesi ⁇ prior to in si tu expan ⁇ ion.
  • the tubular prosthe ⁇ is will usually be pre-coated or covered with the material of the sealing layer prior to introduction of the prosthesis to the body lumen.
  • the material of the sealing layer may be introduced in an initial step prior to introduction of the tubular prosthesis.
  • a fluid delivery catheter will be employed to apply the sealing layer material in a fluid or semi-solid state over at least a portion of the interface region. The fluid delivery catheter is removed, and a prosthesis delivery catheter is then introduced to the target location.
  • the prosthe ⁇ i ⁇ carried by the catheter may then be expanded in si tu ⁇ o that it engage ⁇ and conforms to the material of the ⁇ ealing layer.
  • Apparatu ⁇ according to the pre ⁇ ent invention include ⁇ tubular prosthese ⁇ comprising an expansible tubular frame having a sealing layer formed at least partially over an exterior surface thereof.
  • the sealing layer may be formed of any of the materials described above.
  • the apparatus according to the pre ⁇ ent invention further includes a fluid delivery catheter comprising a catheter body having a proximal end and a distal end.
  • An outer balloon and an inner balloon are disposed on the catheter near its distal end.
  • the outer balloon is positioned over the inner balloon and includes a plurality of fluid delivery ports formed over its surface.
  • the outer balloon is connected to a first lumen within the catheter body and can receive a fluid or semi-solid sealing material therethrough.
  • the inner balloon is connected to a ⁇ econd lumen within the catheter body and can receive an expan ⁇ ion medium therethrough.
  • the sealing material By fir ⁇ t filling the outer balloon with the fluid or semi-solid sealing material, and thereafter expanding the inner balloon within the outer balloon, the sealing material is extruded outwardly through the fluid delivery ports in an annuler layer over the inner surface of the luminal wall.
  • the prosthesis may then be delivered to the body lumen and expanded so that it becomes embedded in the layer of sealing material.
  • the sealing material hardens, optionally with the application of energy conforming to the exterior of the prosthesi ⁇ and providing a substantially permanent anchor and barrier to the bypass of body fluid.
  • FIG. 1-3 illustrate prior art implantation of a va ⁇ cular pro ⁇ thesis.
  • Fig. 4 i ⁇ a cro ⁇ s-sectional view of a vascular prosthesi ⁇ embedded in a ⁇ ealing layer in the region of an aneury ⁇ m according to the pre ⁇ ent invention.
  • Fig. 6 is a cros ⁇ - ⁇ ectional view taken along line 6-6 of Fig. 4.
  • Fig. 7 illu ⁇ trate ⁇ a tubular prosthesi ⁇ constructed in accordance with the principles of the pre ⁇ ent invention, in a radially compre ⁇ ed configuration.
  • Fig. 8 illu ⁇ trate ⁇ the tubular prosthesis of Fig. 7 in a radially expanded configuration.
  • Fig. 9 illustrates a bifurcated prosthesis constructed in accordance with the principles of the present invention.
  • Fig. 10 illustrates a fluid delivery catheter intended for the intraluminal delivery of a sealing material for use in the methods of the pre ⁇ ent invention.
  • Fig ⁇ . 11A-11F illustrate a particular embodiment of the method of the present invention employing an initial sealing material delivery step followed by a ⁇ eparate pro ⁇ thesis implantation step.
  • Fig. 12 illustrates a first embodiment of a ⁇ ealing sleeve intended for implantation at the bifurcation of the abdominal aorta into the left and right iliac arteries.
  • Fig. 13 is an alternate embodiment of a sealing sleeve for implantation at the bifurcation of the abdominal aorta into the right and left iliac arteries.
  • Fig. 14 illu ⁇ trate ⁇ the implantation of a vascular graft between a pair of sealing sleeve ⁇ to treat an abdominal aortic aneurysm.
  • Fig. 15 illustrates an alternative anchoring of the vascular graft of Fig. 14 with a sealing sleeve which extends into the renal arteries.
  • Fig. 16 illustrates use of the vascular prosthesis of the present invention for sealing at each end of a previously implanted prosthe ⁇ is.
  • Fig. 17 illustrates an alternative embodiment of the sealing prosthesi ⁇ of the present invention.
  • Fig. 18 illustrates one end of a tubular prosthesis having a plurality of resilient tines which support a fabric sealing layer circumferentially thereabout.
  • Fig. 19 is a detailed ⁇ ection view taken along line 19-19 in Fig. 18.
  • the present invention provides methods and apparatus for the implantation of tubular prostheses in body lumens.
  • the present invention will find use in the placement of any type of graft or stent in a wide variety of body lumens, including blood vessels, the ureter, the urethra, the biliary tract, and the like.
  • the methods and devices will also find use in the creation of temporary or long-term lumens, such as the formation of fistulas.
  • the preferred use of the pre ⁇ ent invention i ⁇ for the percutaneous placement of endovascular graft ⁇ and ⁇ tents for the treatment of diseases of the vasculature, particularly aneury ⁇ m ⁇ , ⁇ tenoses, and the like.
  • Tubular prostheses will comprise a tubular body having a radially compres ⁇ ed configuration and a radially expanded configuration.
  • the tubular pro ⁇ the ⁇ is is introduced to a target size within the body lumen with the tubular body in its radially compressed configuration. After proper placement at the target location, the tubular body will be radially expanded, either by releasing the body to permit self-expan ⁇ ion or by applying a force to the body to cause radial expansion, as described in more detail below.
  • the tubular body of the pro ⁇ thesis will typically have a length in the range from about 30 mm to 500 mm, usually from 80 mm to 200 mm, with an expanded diameter in the range from 2 mm to 45 mm, usually being in the range from 5 mm to 25 mm, and a compressed diameter in the range from 1 mm to 9 mm, usually from 3.5 mm to 7 mm.
  • These dimen ⁇ ions are particularly suitable for graft structures intended for treating va ⁇ cular aneury ⁇ m ⁇ .
  • the tubular body of the pro ⁇ the ⁇ is can have any configuration normally employed for such medical prostheses, including sleeve ⁇ , lattices, counter-wound helices, braids, slotted tubes, and the like.
  • the tubular body may be linear (i.e., in the form of a single cylindrical tube with a first end, a second end, and a lumen therebetween) , or branched (i.e., in the form of a "Y" with a first end, a pair of branched, second ends, and lumens therebetween, such as tho ⁇ e typically used for aortic aneurysms extending from the abdominal aorta into the iliac arteries) , or in any other configuration used for vascular and other luminal prosthese ⁇ now or in the future.
  • tubular body of the present invention can be composed of a wide variety of biologically compatible materials, including metals, organic polymers, and combinations thereof.
  • the materials can further be selected or modified to provide a variety of secondary characteristics, such as shape memory, drug delivery, bioabsorbability, radiopaqueness, and the like.
  • the tubular body will be composed of two or more different materials in order to provide de ⁇ ired characteri ⁇ tic ⁇ to the body.
  • Such different materials can be incorporated in a variety of ways. For example, different interwoven helices, braids, or other elements can be ' composed of different materials.
  • the interwoven elements can themselves be composed of two or more materials, particularly when the flat ribbons are compo ⁇ ed of multiple individual filaments.
  • different materials can be laminated over within the body of the tubular prosthe ⁇ i ⁇ to provide for desired properties.
  • Preferred materials of construction include tantalum, titanium, nickel-titanium alloy (Nitinol' 5 ) , polyester (e.g. polyethylene terephthalate) , and polytetrafluoroethylene (PTFE) .
  • the present invention particularly provide ⁇ for a ⁇ ealing layer to be di ⁇ po ⁇ ed over a tubular pro ⁇ the ⁇ i ⁇ body which has been implanted in the patient's body lumen.
  • the ⁇ ealing layer will provide for an e ⁇ entially fluid-tight ⁇ eal over at lea ⁇ t one circumferential band di ⁇ po ⁇ ed in an interface region between the exterior ⁇ urface of the tubular pro ⁇ thesis body and an inner wall of the body lumen.
  • the sealing layer will fill or cover ⁇ ub ⁇ tantially the entire interface region, but such complete coverage will not always be neces ⁇ ary. Sometime ⁇ , it will be sufficient to form only a single band of the sealing layer material at one or both ends of a linear prosthesis body, or at one, two, or three ends of a bifurcated prosthesis body.
  • the sealing layer will usually serve in addition to anchor the pro ⁇ the ⁇ i ⁇ body in the patient's body lumen.
  • the sealing layer may immediately, or over time, assume a generally a solid (although preferably compliant) configuration which both blocks fluid flow (e.g. prevents incursion of fluid into an aneury ⁇ m which i ⁇ being treated with a vascular pro ⁇ thesis) and which also firmly anchors the prosthe ⁇ i ⁇ at the target location.
  • an adhesive may be placed over at least a portion of the interface between the sealing layer and the interior of the blood vessel wall .
  • the sealing layer which is eventually formed will have a thickness sufficient to provide both the occlusion and anchoring function ⁇ de ⁇ cribed above.
  • the thickness of the sealing layer will generally be between about 0.5 mm to 5 mm, usually from 1 mm to 3 mm, depending on the nature of both the sealing layer material and the tubular prosthesi ⁇ body.
  • gel ⁇ and foam ⁇ will typically be thicker than will be adhesives, as described in more detail below.
  • the sealing layer may be composed of a wide variety of materials, u ⁇ ually being in the form of a gel, foam, sponge, adhesive, biological polymer, compliant ⁇ leeve, microporou ⁇ me ⁇ h, or the like.
  • the material may initially be in a fluid (liquid) or ⁇ emi-solid state, where the material may be at least partially hardened after introduction to the target location within the body lumen and in si tu expansion of the tubular prosthe ⁇ i ⁇ body.
  • the ⁇ ealing layer material may be hydrophilic, particularly being in the form of a hydrophilic gel or foam, ⁇ o that it may ab ⁇ orb body fluid ⁇ to enhance occlusion of the interface region.
  • Such hydrophilic materials are often highly compliant and conformable and are particularly suitable for conforming to changes in the shape of the luminal wall which may occur over time.
  • the sealing layer may also be in the form of a resilient or elastomeric sleeve which partially or fully occupies the interface region.
  • the elastomeric sleeve can be a tubular member, such as an extruded elastomer, which is placed over the tubular prosthesi ⁇ body before expansion.
  • the sleeve could be a self-expanding mechanical assembly formed from a compliant fabric or other material, with internal springs or other mechani ⁇ ms for providing the desired resilience and thickne ⁇ .
  • Suitable gel material ⁇ include hydrogels, particularly acrylates and acrylamides, such as polyacrylamide, polyhydroxyethyl methacrylate, and the like. These materials, which will typically be applied to the exterior surface of the tubular body of the prosthesis prior to expansion, may be formulated to provide for both surface adhesion and swellability. These materials may be applied either in circumferential rings at either single or multiple ends of the tubular graft structure, or to cover substantially the entire outer surface of the tubular prosthesis body.
  • Hydrophilic sealing cuffs which absorb water and expand to seal about the periphery of the prosthesis body can be fabricated in a number of ways.
  • a water permeable membrane can be made from a woven or knitted material composed of polyester, polyethylene, or polyethyleneterephthalate (PTFE) .
  • PTFE polyethyleneterephthalate
  • a suitable woven PTFE is available under the tradename GORTEX ® .
  • a hydrogel can be placed inside the water permeable membrane. Suitable hydrogels include polyethylene glycol (PEG) /poly-hydroxyethyl methacrylate (pHEMA) , commercially available under the tradename HYDRON ® .
  • Suitable foams include polyurethanes (e.g. open cell polyurethanes), silicones, and the like. Such foams will generally be applied prior to implantation of the tubular prosthesis body, typically using a fluid delivery catheter a ⁇ described in more detail below.
  • Suitable adhesive ⁇ include acrylate ⁇ , epoxie ⁇ (including two-part curable epoxies) ,fibrin-based adhesives, and other specialized adhesive ⁇ .
  • An exemplary adhesive is a crystalline polymer which changes from a non-tacky crystalline state to an adhesive gel state when the temperature is raised from room temperature to body temperature. Such material is available under the trade name Intillemer' 1 ' adhe ⁇ ive, available from Landec Corp.
  • Suitable biological polymer ⁇ include proteins, such as collagen, fibrin, fibrinogen, elastin, and the like, which can be either formed over the tubular prosthesis body prior to implantation, or delivered to the target site in the body lumen prior to delivery of the tubular prosthesis body.
  • proteins include fibrin-ba ⁇ ed glue ⁇ which include both a fibrinogen component and a thrombin component to produce fibrin.
  • An exemplary material for the compliant ⁇ leeve i ⁇ microporous silicone rubber such as that described in U.S. Patent Nos. 3,890,107 and 5,348,788, the full disclosures of which are incorporated herein by reference.
  • Such materials may be molded or machined into sleeve ⁇ which are disposed between the exterior of the prosthesi ⁇ and the interior of the lumenal wall.
  • the ⁇ leeves may be pre-loaded over the tubular prosthe ⁇ is (i.e., prior to delivery and in si tu expansion of the combined prosthesis and sleeve) or may be delivered to and implanted at the target location in the body lumen prior to delivery and in si tu expansion of the prosthe ⁇ is.
  • the prosthesi ⁇ 10 includes a tubular prothe ⁇ i ⁇ body 12, which is illustrated as a linear, cylindrical prosthesis.
  • the prosthe ⁇ is body 12 is implanted within a sealing layer 14 which conform ⁇ to the exterior surface of the prosthe ⁇ is body 12 and which ⁇ ub ⁇ tantially fills and occludes the annular interface region between the outer surface of the prothesis body 12 and the inner wall of the blood vessel lumen at each end of the aneurysm A, as best seen in the cro ⁇ - ⁇ ectional views of Figs. 5 and 6.
  • the sealing layer 14 may have been applied within the blood ves ⁇ el lumen prior to implantation of the tubular pro ⁇ the ⁇ i ⁇ body 12, or may have been introduced over the exterior of the prosthesis body prior to implantation.
  • a prothesis 20 comprises a tubular prosthesis body 22 (which may be self-expanding or malleable, as generally described above) having a sealing layer 24 formed over its exterior surface.
  • the sealing layer 24 may have any of the forms described above, and will be formed over the prosthesi ⁇ body 22 prior to implantation. Thus, the sealing layer 24 will be configured to radially expand together with the prosthesis body 22
  • the sealing layer 24 will ⁇ till be sufficiently resilient and conformable to provide for the occlusion of the interface region between the prosthesis and the inner wall of the body lumen.
  • An exemplary branched prosthesi ⁇ having a "Y"-configuration and con ⁇ tructed in accordance with the principles of the present invention is illustrated in Fig. 9.
  • the prosthesis body 32 may be of conventional construction, but includes a circumferential band of sealing material at each of the end ⁇ thereof.
  • the pro ⁇ thesis could also have a cross or "X" - configuration where bands of sealing material are provided at one or more of the four branches (not illustrated) .
  • Catheter 40 designed to deliver fluid or semi-solid phase sealants to interior of a body lumen will be described.
  • Catheter 40 includes catheter body 42 having a distal end 44 and a proximal end 46.
  • An outer balloon 48 and inner balloon 50 are coaxially mounted near the distal end 44 of the catheter body 42.
  • the outer balloon 48 is connected through a lumen in body 42 to a first port 52 in proximal hou ⁇ ing 54 to receive the fluid or semi-solid phase sealant.
  • the inner balloon 50 is connected through a second lumen in catheter body 42 to receive inflation medium through a second port 56 in the proximal hub 54.
  • a fluid or ⁇ e i- ⁇ olid sealant may first be delivered to the interior of outer balloon 48 over the inner balloon 50.
  • the sealant may be expelled outward through a plurality of fluid delivery ports 58 disposed sub ⁇ tantially uniformly over the outer cylindrical ⁇ urface of the outer balloon 58.
  • the outer balloon 58 will be formed from a non-compliant material, ⁇ uch as polyethyleneterphthalate.
  • the inner balloon 50 is preferably formed from an elastomeric material, such as silicone rubber latex rubber, or polyurethane.
  • the catheter body 42 is configured to be introduced over a movable guidewire, including guidewire port 60 extending therethrough.
  • fluid delivery catheter 40 i ⁇ introduced to a region of an aneury ⁇ m A in blood vessel BV over a guidewire GW, as illustrated in Fig. IIA.
  • the outer balloon 48 is then at least partially filled with a fluid or semi-solid sealant S, a ⁇ illu ⁇ trated in Fig. 11B.
  • the inner balloon 50 i ⁇ then expanded to expel the ⁇ ealant through the port ⁇ 58 into the region of aneurysm A, as illustrated in Fig. IIC.
  • a graft delivery catheter 60 may then be introduced to the blood vessel BV so that a tubular prosthesis body 62 is positioned within the sealant S, a ⁇ illu ⁇ trated in Fig. HE.
  • the prosthesi ⁇ body 62 is malleable and expanded by an internal balloon 64. It will be appreciated, however, that the prosthe ⁇ is body 62 could be in the form of a ⁇ elf-expanding (re ⁇ ilient) tube which i ⁇ released from radial constraint by a different delivery catheter.
  • prosthesis body 62 After the prosthesis body 62 is expanded and/or released, it will compre ⁇ radially outwardly against the sealant material S to compress and conform the sealant into the interface region, as illustrated in Fig. HF. Sealant material may then at least partially harden (optionally by applying energy to cure the material) to provide both for occlusion of the interface region (to prevent bypass flow of blood into the aneurysm A) and also to anchor the prosthesis body 62 in place.
  • a sealing layer in the form of a bifurcated tube 100 includes a trunk segment 102 and a pair of leg segment ⁇ 104 and 106.
  • the ⁇ leeve 100 will be composed of a resilient, preferably "spongy" material which can be introduced into the base of the abdominal aorta so that the legs 104 and 106 into the right and left iliac arteries, respectively.
  • each of the trunk 102 and right and left leg ⁇ 104 and 106 will comprise structure, such as a self- expanding spring 108, which will radially expand the sleeve at each of its openings so that the sleeve will self-anchor in the aorta and iliac arteries.
  • FIG. 13 shows an alternative 120 which is generally similar to the sleeve 100, expect that self-expanding tubular elements 122, 124, and 126, are provided in the trunk 128, leg 130, and leg 132 respectively.
  • These self-expanding tubes are generally similar to the tubular prosthesis structures described previously and provide the necessary mechanical support to anchor the sleeve 120 at the bifurcation of the abdominal aorta into the iliac arteries.
  • the sleeve 120 will not itself form the necessary vascular graft over the aneurysm, but rather will form a resilient anchor at the base of the aorta for subsequent implantation of a separate vascular graft, as de ⁇ cribed in below in connection with Fig ⁇ 14 and 15.
  • the preferred material for the ⁇ leeves 100 and 120 will be micro porous silicone rubber, as described above.
  • the sleeve 100 or 120 can be implanted at the base of an abdominal aortic aneurysm AAA so that the trunk portion 102 or 128 extends into the aorta and the leg portions 104 or 130 and 106 or 132 extend into the right iliac RI and left iliac LI, respectively.
  • An upper sleeve anchor 140 will be implanted above the aneurysm AAA and below the renal arteries RA.
  • the sleeve 140 will be composed of a similar resilient material, preferably silicone rubber, and will usually be self-expanding so that it can be initially placed at the desired location.
  • a vascular prosthesis P which may be any self-expanding or expandable vascular graft as described previously, may then be implanted between the upper sleeve 140 and base sleeve 100 or 120.
  • a simple, linear pro ⁇ thesis can be used to treat an aortic aneurysm AAA.
  • additional prosthesis (not shown) could be implanted in each of the leg ⁇ 104/130 and 106/132 of the sleeve in order the further anchor the sleeve and provide desired support within the iliac arteries.
  • a sleeve 150 (Fig. 15) could be provided having ⁇ ide branches 152 and 154 which extend into the renal arterie ⁇ RA. Such a sleeve would be particularly desirable for aneurysms which extend upwardly and approach the renal arteries.
  • tubular prostheses of the present invention will also find use in sealing at one or more ends of a previously implanted prosthesis as shown in Fig. 16.
  • a prosthesis 200 (which may be a conventional graft or stent or may itself be a "sealing" prosthesi ⁇ according to the pre ⁇ ent invention) is initially implanted in an aneurysm A. Over time, the length of the aneury ⁇ m may increa ⁇ e, creating path ⁇ at one or both end ⁇ for blood to bypas ⁇ the prosthesis into the aneurysm. This situation may be corrected by implanting additional sealing prosthe ⁇ is 202 which are con ⁇ tructed in accordance with any of the designs described herein.
  • the prosthe ⁇ es 202 will be disposed inside each end of the initial or central pro ⁇ the ⁇ is 200 into the adjacent lumen of the blood vessel.
  • the prostheses 202 are shown to include body 204 and sealing layer 206, and the sealing layer is able to conform to the end transition between the pro ⁇ the ⁇ i ⁇ 200 and the blood vessel wall, providing an effective seal again ⁇ t blood bypass and a further anchor of the prosthe ⁇ is 200 in place. While particularly useful for post-placement sealing, the method of introducing the sealing pro ⁇ theses into one or more end ⁇ of a primary graft would also be useful at the time the primary graft is first introduced.
  • a prosthesis 250 comprises a tubular body 252 and an inner liner 254.
  • the tubular body comprises a plurality of spring-like fingers 256 which support an outer liner 258 radially outward.
  • the inner liner 254 and outer liner 258 may be compo ⁇ ed of the ⁇ ame or different material ⁇ , typically being polyester, polytetrafluoroethylene (PTFE) , polyurethane, non-woven fabric, polymeric sheet material or the like.
  • PTFE polytetrafluoroethylene
  • Figs. 18 and 19 show yet another alternative construction for a sealing layer according to the present invention.
  • the sealing layer comprise ⁇ a fabric or ' membrane layer 300 which opens conically about an end 302 of a prosthesis 304.
  • the layer 300 is shown to be supported by a plurality of tines 306 which are connected to the end of the prosthe ⁇ i ⁇ 304.
  • the tines 306 are formed integrally a ⁇ part of a metallic framework 310 of the prosthesis, but it will be appreciated that the tines could be welded or otherwise attached to the framework.
  • a fabric liner 316 is shown to be folded from the interior of the prosthe ⁇ i ⁇ back into and over a V-shaped cavity 318 defined by the tines 306. It will be appreciated that, upon deployment in a blood vessel, the layer 300 will engage and conform to the interior surface of the vessel and the layer will seal the end of the prosthe ⁇ is 304 to inhibit by-pass blood flow. It will be further appreciated that the sealing layer 300 could be formed in a variety of other specific design ⁇ , including an un ⁇ upported or partially ⁇ upported fabric or membrane which i ⁇ held open to ⁇ eal against the blood vessel wall by the blood flow itself which applies pressure within the cavity 318.

Abstract

A tubular prosthesis (10) is implanted at a target location within a body lumen by trans-luminal placing and embedding an expansible prosthesis body within a sealing layer (14). The sealing layer occludes at least a circumferential band within an interface region between the prosthesis body and the inner wall of the body lumen, thus providing for blockage of body lumen flow past the prosthesis. The sealing layer may be introduced prior to or simultaneously with the prosthesis body. A tubular prosthesis may be implanted in blood vessels, particularly to protect aneurysms.

Description

METHODS AND APPARATUS FOR CONFORMABLY SEALING PROSTHESES WITHIN BODY LUMENS
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to methods and apparatus for the endoluminal placement of tubular prostheses, such as grafts, stents, and other structures. More particularly, the present invention relates to the implantation of luminal prostheses in a sealing layer within a body lumen. Vascular aneurysms are the result of abnormal dilation of a blood vessel, usually resulting from disease and/or genetic predisposition which can weaken the arterial wall and allow it to expand. While aneurysms can occur in any blood vessel, most occur in the aorta and peripheral arteries, with the majority of aortic aneurysms occurring in the abdominal aorta, usually beginning below the renal arteries and often extending distally into one or both of the iliac arteries.
Aortic aneurysms are most commonly treated in open surgical procedures where the diseased vessel segment is bypassed and repaired with an artificial vascular graft. While considered to be an effective surgical technique, particularly considering the alternative of a usually fatal ruptured abdominal aortic aneurysm, conventional vascular graft surgery suffers from a number of disadvantages. The surgical procedure is complex and requires experienced surgeons and well-equipped surgical facilities. Even with the best surgeons and equipment, however, the patientε being treated frequently are elderly and weakened from cardiovascular and other diseases, reducing the number of eligible patients. Even for eligible patients, conventional aneurysm repair surgery performed prior to rupture has a relatively high mortality rate, usually from 2% to 10%. Morbidity related to the conventional surgery includes myocardial infarction, renal failure, impotence, paralysis, and other conditions. Additionally, even with successful surgery, recovery can take several weeks and often requires a lengthy hospital stay.
In order to overcome some or all of these drawbacks, endovascular graft placement procedures for the treatment of aneurysms have been proposed. Generally, such endovascular procedures will deliver a radially compressed graft intravascularly to the aneurysm. The graft is then expanded in si tu, either by releasing a self-expanding graft or by internally expanding a malleable graft (e.g. using a balloon catheter) to protect the aneurysm. Usually, the vascular graft will comprise both a frame and a liner, where the frame provides the necessary mechanical support and the liner provides the necessary blood barrier.
While highly promising, the endovascular placement of vascular grafts is problematic in several respects. In contrast to surgically implanted grafts, which are sutured in place, endovascularly placed grafts can be difficult to anchor and position. Reliance on the outward spring-force of a self-expanding graft is not always sufficient. Malleable grafts, in contrast, may be easier to initially anchor but may be less able to expand and contract with the blood vessel during the continuous pulse of the patient. While the use of hooks or barbs for anchoring grafts into the blood vessel wall has been proposed, such devices can be traumatic and can loosen from the blood vessel wall over time. As the anchoring of the vascular prosthesis loosens over time, blood can begin to bypass the graft and flow into the region between the graft and the blood vessel wall. Such misdirected blood flow into the aneurysm can again expose the patient to risk of aneurysm rupture and its consequences. Additionally, heretofore, it has been difficult to radially reinforce both self-expanding and malleable graft structures to help in maintaining the structures within the blood vessel.
Referring to Prior Art Figs. 1-3, the problem of blood flow leakage past a graft structure 10 implanted within the region of an aneurysm A in a blood vessel BV is illustrated. While the graft 10 may be adequately anchored on each side of the aneurysm A, as illustrated in Fig. 1, over time the inner surface of the blood vessel lumen can partially separate from the outer surface of the graft 10, as illustrated in Figs. 2 and 3. Such separations S can allow bypass blood flow into the region of the aneurysm A.
For these reasons, it would be desirable to provide improved luminal prostheses and methods for their implantation which can overcome at least some of the difficulties described above. In particular, it would be desirable to provide intraluminal prostheses and methods for their implantation which would provide a generally fluid tight seal circumscribing at least one end of the prosthesis, and preferably both ends or the entire length of the prosthesis, to prevent bypass blood or other fluid flow into the interstitial region between the inner wall of the body lumen and the outer surface of the prosthesis. In particular, it would be desirable if such improved prostheses and methods for their implantation would provide for sealing of the prosthesis which would resist separating from the intraluminal wall in order to prevent such bypass flow in a long-term or permanent fashion after implantation of the prosthesis. In some cases, it will be desirable to provide methods which permit such sealing implantation when using otherwise conventional prosthesis structures, such as vascular stents and grafts. In other cases, it will be desirable to provide improved prosthesis structures which incorporate features which provide for such sealing implantation when implanted using methods according to present invention.
2. Description of the Background Art
The delivery of polymerizable fluids to body tissues for a variety of purposes, including "paving" of vascular lumens, has been proposed. See, for example, PCT Publications WO 94/24962 and WO 94/21324, and U.S. Patent No. 5,092,841. Luminal prostheses which are delivered in a compliant state and hardened in si tu by exposure to heat, radiation, or other polymerization-initiating event are described in U.S. Patent Nos. 5,344,444; 5,334,201; and 5,100,429; EP 521573; and de Vries et al. , "Instant Tubular Prosthesis: A Totally New Concept," International Congress VII Endovascular Interventions, Phoenix, Arizona, February 1994. A fabric prosthesis which is secured to an inner vascular wall by a contact adhesive, such as cyanoacrylate, is described in U.S. Patent No. 4,577,631. The use of autologous fibrin glue for sealing porous, fabric grafts prior to open surgical implantation is described in Kjaergard and Weis-Fogh (1994) Card. Surg. 2:45-46. A tubular prosthesis having an annular cavity for receiving a plastic material to enlarge and anchor the prosthesis within a blood vessel is described in U.S. Patent No. 5,156,620. A tubular prosthesis having inflatable cuffs on each end is described in U.S. Patent No. 3,991,767. A tubular prosthesis having everted cuffs for receiving sutures is described in U.S. Patent No. 4,728,328. A tubular stent having hook-like projections over its outer surface is described in U.S. Patent No. 5,167,614. A tubular stent having a plurality of self-locking fingers extending outward from its outer surface is described in U.s. Patent No. 5,344,426. A fluid delivery catheter comprising concentric lumens in a balloon structure is described in U.S. Patent No. 5,295,962. A vascular prosthesis comprising two porous concentrically associated tubes with a helical spring enclosed therebetween is disclosed in U.S. Patent No. 4,130,904. A vascular prosthesis comprising a multilaminar tubular member is disclosed in U.S. Patent No. 5,354,329. Microporous materials suitable for the fabrication of prosthetic devices are described in U.S. Patent Nos. 3,890,107 and 5,348,788.
SUMMARY OF THE INVENTION
The present invention provides methods and apparatus for the transluminal positioning of tubular prostheses at a target location within a body lumen. The tubular prostheses are suitable for a wide variety of therapeutic uses, including stenting of the ureter, urethra, biliary tract, and the like. The devices and methods will also find use in the creation of temporary or long-term lumens, such aε the formation of fistulas. The present invention will find its greatest use, however, in the placement of endovascular grafts into blood vessels for the treatment of abdominal and other aneurysms, vascular stenoses, and the like.
According to the method of the present invention, a tubular prosthesis is delivered to the target site within the body lumen in a radially compressed configuration and is expanded in si tu at the target location so that an exterior εurface of the prosthesis engages an inner wall of the body lumen over an interface region therebetween. Radial expansion of the prosthesis may be effected in any conventional manner, including the use of a balloon catheter for expanding malleable prostheses, the release of compressed, self-expanding prostheseε from suitable delivery catheters, and the like. The present invention particularly provides for expansion of the prostheseε into a sealing layer which is disposed in or over at least a portion of the interface region. The sealing layer may be disposed within substantially the entire interface region, or may be disposed over one or more discrete, circumferential bands within the interface region. Usually, the sealing layer will be disposed at least at each end of the tubular prosthesis in order to provide a barrier against the bypass leakage of fluid into portions of the interface region therebetween. Preferably, the εealing layer will occupy εubεtantially the entire interface region.
The sealing layer may be composed of virtually any material which is biocompatable and capable of conforming to the interface region between the outer wall of the tubular prostheεis and the inner wall of the body lumen. Exemplary materials include gels, foams, adhesives, biological polymers, compliant sleeveε, sponges, porous matrices and meshes, and the like. In some caseε, the materialε are initially present on the prosthesis or delivered in a fluid or semi-solid εtate to the interface region, and thereafter cured or hardened to achieve the final, deεired geometry. Additionally, the sealing layer may be composed of materials which expand in si tu in order to fully conform to the geometry of the interface region, e.g. including materials εuch as hydrophilic gels, hydrophilic foams, and the like. An exemplary material for the sealing layer comprises a microporous mesh, particularly composed of silicone rubber and similar materials .
In a first particular aspect of the present invention, the sealing layer may be initially formed or disposed over at least a portion of the exterior surface of the tubular prosthesiε prior to in si tu expanεion. In such cases, the tubular prostheεis will usually be pre-coated or covered with the material of the sealing layer prior to introduction of the prosthesis to the body lumen. In a second particular aspect of the method of the present invention, the material of the sealing layer may be introduced in an initial step prior to introduction of the tubular prosthesis. Usually, a fluid delivery catheter will be employed to apply the sealing layer material in a fluid or semi-solid state over at least a portion of the interface region. The fluid delivery catheter is removed, and a prosthesis delivery catheter is then introduced to the target location. The prostheεiε carried by the catheter may then be expanded in si tu εo that it engageε and conforms to the material of the εealing layer.
Apparatuε according to the preεent invention includeε tubular prostheseε comprising an expansible tubular frame having a sealing layer formed at least partially over an exterior surface thereof. The sealing layer may be formed of any of the materials described above.
The apparatus according to the preεent invention further includes a fluid delivery catheter comprising a catheter body having a proximal end and a distal end. An outer balloon and an inner balloon are disposed on the catheter near its distal end. The outer balloon is positioned over the inner balloon and includes a plurality of fluid delivery ports formed over its surface. The outer balloon is connected to a first lumen within the catheter body and can receive a fluid or semi-solid sealing material therethrough. The inner balloon is connected to a εecond lumen within the catheter body and can receive an expanεion medium therethrough. By firεt filling the outer balloon with the fluid or semi-solid sealing material, and thereafter expanding the inner balloon within the outer balloon, the sealing material is extruded outwardly through the fluid delivery ports in an annuler layer over the inner surface of the luminal wall. The prosthesis may then be delivered to the body lumen and expanded so that it becomes embedded in the layer of sealing material. The sealing material hardens, optionally with the application of energy conforming to the exterior of the prosthesiε and providing a substantially permanent anchor and barrier to the bypass of body fluid.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1-3 illustrate prior art implantation of a vaεcular proεthesis.
Fig. 4 iε a croεs-sectional view of a vascular prosthesiε embedded in a εealing layer in the region of an aneuryεm according to the preεent invention.
Fig. 5 iε a croεε-sectional view taken along line 5-5 of Fig. 4.
Fig. 6 is a crosε-εectional view taken along line 6-6 of Fig. 4.
Fig. 7 illuεtrateε a tubular prosthesiε constructed in accordance with the principles of the preεent invention, in a radially compreεεed configuration.
Fig. 8 illuεtrateε the tubular prosthesis of Fig. 7 in a radially expanded configuration.
Fig. 9 illustrates a bifurcated prosthesis constructed in accordance with the principles of the present invention.
Fig. 10 illustrates a fluid delivery catheter intended for the intraluminal delivery of a sealing material for use in the methods of the preεent invention.
Figε. 11A-11F illustrate a particular embodiment of the method of the present invention employing an initial sealing material delivery step followed by a εeparate proεthesis implantation step.
Fig. 12 illustrates a first embodiment of a εealing sleeve intended for implantation at the bifurcation of the abdominal aorta into the left and right iliac arteries.
Fig. 13 is an alternate embodiment of a sealing sleeve for implantation at the bifurcation of the abdominal aorta into the right and left iliac arteries.
Fig. 14 illuεtrateε the implantation of a vascular graft between a pair of sealing sleeveε to treat an abdominal aortic aneurysm.
Fig. 15 illustrates an alternative anchoring of the vascular graft of Fig. 14 with a sealing sleeve which extends into the renal arteries. Fig. 16 illustrates use of the vascular prosthesis of the present invention for sealing at each end of a previously implanted prostheεis.
Fig. 17 illustrates an alternative embodiment of the sealing prosthesiε of the present invention. Fig. 18 illustrates one end of a tubular prosthesis having a plurality of resilient tines which support a fabric sealing layer circumferentially thereabout.
Fig. 19 is a detailed εection view taken along line 19-19 in Fig. 18.
DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENTS
The present invention provides methods and apparatus for the implantation of tubular prostheses in body lumens. The present invention will find use in the placement of any type of graft or stent in a wide variety of body lumens, including blood vessels, the ureter, the urethra, the biliary tract, and the like. The methods and devices will also find use in the creation of temporary or long-term lumens, such as the formation of fistulas. The preferred use of the preεent invention, however, iε for the percutaneous placement of endovascular graftε and εtents for the treatment of diseases of the vasculature, particularly aneuryεmε, εtenoses, and the like. Tubular prostheses according to the present invention will comprise a tubular body having a radially compresεed configuration and a radially expanded configuration. The tubular proεtheεis is introduced to a target size within the body lumen with the tubular body in its radially compressed configuration. After proper placement at the target location, the tubular body will be radially expanded, either by releasing the body to permit self-expanεion or by applying a force to the body to cause radial expansion, as described in more detail below.
The tubular body of the proεthesis will typically have a length in the range from about 30 mm to 500 mm, usually from 80 mm to 200 mm, with an expanded diameter in the range from 2 mm to 45 mm, usually being in the range from 5 mm to 25 mm, and a compressed diameter in the range from 1 mm to 9 mm, usually from 3.5 mm to 7 mm. These dimenεions are particularly suitable for graft structures intended for treating vaεcular aneuryεmε.
The tubular body of the proεtheεis can have any configuration normally employed for such medical prostheses, including sleeveε, lattices, counter-wound helices, braids, slotted tubes, and the like. The tubular body may be linear (i.e., in the form of a single cylindrical tube with a first end, a second end, and a lumen therebetween) , or branched (i.e., in the form of a "Y" with a first end, a pair of branched, second ends, and lumens therebetween, such as thoεe typically used for aortic aneurysms extending from the abdominal aorta into the iliac arteries) , or in any other configuration used for vascular and other luminal prostheseε now or in the future.
Configurationε suitable for use as the tubular body component of the tubular prostheses of the present invention are well described in the patent and medical literature. See, for example, U.S. Patent Nos. 5,219,355; 5,211,658; 5,104,399; 5,078,726; 4,820,298; 4,787,899; 4,617,932; 4,562,596;
4,577,631; and 4,140,126, the full disclosures of which are incorporated herein by reference. Preferred constructions for the tubular body of the present invention are described in copending Application Serial Noε . 08/255,681, filed on June 8, 1994, and 08/414,995, filed on March 31, 1995, the full disclosureε of which are incorporated herein by reference. The tubular body of the proεthesis can be composed of a wide variety of biologically compatible materials, including metals, organic polymers, and combinations thereof. The materials can further be selected or modified to provide a variety of secondary characteristics, such as shape memory, drug delivery, bioabsorbability, radiopaqueness, and the like. Frequently, the tubular body will be composed of two or more different materials in order to provide deεired characteriεticε to the body. For example, it may be desirable to fabricate the tubular body both from organic polymers, which can provide flexibility and impermeability, and from metallic elements which can provide self-expansion, resilience, and structural integrity. Such different materials can be incorporated in a variety of ways. For example, different interwoven helices, braids, or other elements can be' composed of different materials.
Alternatively or additionally, the interwoven elements can themselves be composed of two or more materials, particularly when the flat ribbons are compoεed of multiple individual filaments. Additionally, different materials can be laminated over within the body of the tubular prostheεiε to provide for desired properties. Preferred materials of construction include tantalum, titanium, nickel-titanium alloy (Nitinol'5) , polyester (e.g. polyethylene terephthalate) , and polytetrafluoroethylene (PTFE) . The present invention particularly provideε for a εealing layer to be diεpoεed over a tubular proεtheεiε body which has been implanted in the patient's body lumen. The εealing layer will provide for an eεεentially fluid-tight εeal over at leaεt one circumferential band diεpoεed in an interface region between the exterior εurface of the tubular proεthesis body and an inner wall of the body lumen. Often, the sealing layer will fill or cover εubεtantially the entire interface region, but such complete coverage will not always be necesεary. Sometimeε, it will be sufficient to form only a single band of the sealing layer material at one or both ends of a linear prosthesis body, or at one, two, or three ends of a bifurcated prosthesis body. In addition to at least partially occluding the interface region between the tubular prosthesis body and the body lumen, the sealing layer will usually serve in addition to anchor the proεtheεiε body in the patient's body lumen. Thus, the sealing layer may immediately, or over time, assume a generally a solid (although preferably compliant) configuration which both blocks fluid flow (e.g. prevents incursion of fluid into an aneuryεm which iε being treated with a vascular proεthesis) and which also firmly anchors the prostheεiε at the target location. Optionally, an adhesive may be placed over at least a portion of the interface between the sealing layer and the interior of the blood vessel wall . The sealing layer which is eventually formed will have a thickness sufficient to provide both the occlusion and anchoring functionε deεcribed above. The thickness of the sealing layer will generally be between about 0.5 mm to 5 mm, usually from 1 mm to 3 mm, depending on the nature of both the sealing layer material and the tubular prosthesiε body. For example, gelε and foamε will typically be thicker than will be adhesives, as described in more detail below. The sealing layer may be composed of a wide variety of materials, uεually being in the form of a gel, foam, sponge, adhesive, biological polymer, compliant εleeve, microporouε meεh, or the like. The material may initially be in a fluid (liquid) or εemi-solid state, where the material may be at least partially hardened after introduction to the target location within the body lumen and in si tu expansion of the tubular prostheεiε body. Additionally, the εealing layer material may be hydrophilic, particularly being in the form of a hydrophilic gel or foam, εo that it may abεorb body fluidε to enhance occlusion of the interface region. Such hydrophilic materials are often highly compliant and conformable and are particularly suitable for conforming to changes in the shape of the luminal wall which may occur over time. In contrast to the fluid and semi-solid materials, the sealing layer may also be in the form of a resilient or elastomeric sleeve which partially or fully occupies the interface region. The elastomeric sleeve can be a tubular member, such as an extruded elastomer, which is placed over the tubular prosthesiε body before expansion. Alternatively, the sleeve could be a self-expanding mechanical assembly formed from a compliant fabric or other material, with internal springs or other mechaniεms for providing the desired resilience and thickneεε.
Suitable gel materialε include hydrogels, particularly acrylates and acrylamides, such as polyacrylamide, polyhydroxyethyl methacrylate, and the like. These materials, which will typically be applied to the exterior surface of the tubular body of the prosthesis prior to expansion, may be formulated to provide for both surface adhesion and swellability. These materials may be applied either in circumferential rings at either single or multiple ends of the tubular graft structure, or to cover substantially the entire outer surface of the tubular prosthesis body.
Hydrophilic sealing cuffs which absorb water and expand to seal about the periphery of the prosthesis body can be fabricated in a number of ways. For example, a water permeable membrane can be made from a woven or knitted material composed of polyester, polyethylene, or polyethyleneterephthalate (PTFE) . A suitable woven PTFE is available under the tradename GORTEX®. A hydrogel can be placed inside the water permeable membrane. Suitable hydrogels include polyethylene glycol (PEG) /poly-hydroxyethyl methacrylate (pHEMA) , commercially available under the tradename HYDRON®.
Suitable foams include polyurethanes (e.g. open cell polyurethanes), silicones, and the like. Such foams will generally be applied prior to implantation of the tubular prosthesis body, typically using a fluid delivery catheter aε described in more detail below.
Suitable adhesiveε include acrylateε, epoxieε (including two-part curable epoxies) ,fibrin-based adhesives, and other specialized adhesiveε. An exemplary adhesive is a crystalline polymer which changes from a non-tacky crystalline state to an adhesive gel state when the temperature is raised from room temperature to body temperature. Such material is available under the trade name Intillemer'1' adheεive, available from Landec Corp.
Suitable biological polymerε include proteins, such as collagen, fibrin, fibrinogen, elastin, and the like, which can be either formed over the tubular prosthesis body prior to implantation, or delivered to the target site in the body lumen prior to delivery of the tubular prosthesis body. Specific examples of the proteins include fibrin-baεed glueε which include both a fibrinogen component and a thrombin component to produce fibrin. An exemplary material for the compliant εleeve iε microporous silicone rubber, such as that described in U.S. Patent Nos. 3,890,107 and 5,348,788, the full disclosures of which are incorporated herein by reference. Such materials may be molded or machined into sleeveε which are disposed between the exterior of the prosthesiε and the interior of the lumenal wall. The εleeves may be pre-loaded over the tubular prostheεis (i.e., prior to delivery and in si tu expansion of the combined prosthesis and sleeve) or may be delivered to and implanted at the target location in the body lumen prior to delivery and in si tu expansion of the prostheεis.
Referring now to Figs. 4-6, implantation of a vascular prothesiε 10 within an aneuryεm A in a blood veεεel BV will be described. The prosthesiε 10 includes a tubular protheεiε body 12, which is illustrated as a linear, cylindrical prosthesis. The prostheεis body 12 is implanted within a sealing layer 14 which conformε to the exterior surface of the prostheεis body 12 and which εubεtantially fills and occludes the annular interface region between the outer surface of the prothesis body 12 and the inner wall of the blood vessel lumen at each end of the aneurysm A, as best seen in the croεε-εectional views of Figs. 5 and 6. The sealing layer 14 may have been applied within the blood vesεel lumen prior to implantation of the tubular proεtheεiε body 12, or may have been introduced over the exterior of the prosthesis body prior to implantation.
Referring now to Figs. 7 and 8, a prothesis 20 comprises a tubular prosthesis body 22 (which may be self-expanding or malleable, as generally described above) having a sealing layer 24 formed over its exterior surface. The sealing layer 24 may have any of the forms described above, and will be formed over the prosthesiε body 22 prior to implantation. Thus, the sealing layer 24 will be configured to radially expand together with the prosthesis body 22
(optionally by application of an internal expansion force, e.g. applied from an internal balloon catheter) , as illustrated in Fig. 8. After radial expansion, the sealing layer 24 will εtill be sufficiently resilient and conformable to provide for the occlusion of the interface region between the prosthesis and the inner wall of the body lumen. An exemplary branched prosthesiε having a "Y"-configuration and conεtructed in accordance with the principles of the present invention is illustrated in Fig. 9. The prosthesis body 32 may be of conventional construction, but includes a circumferential band of sealing material at each of the endε thereof. The proεthesis could also have a cross or "X" - configuration where bands of sealing material are provided at one or more of the four branches (not illustrated) .
Referring now to Fig. 10, a catheter 40 designed to deliver fluid or semi-solid phase sealants to interior of a body lumen will be described. Catheter 40 includes catheter body 42 having a distal end 44 and a proximal end 46. An outer balloon 48 and inner balloon 50 are coaxially mounted near the distal end 44 of the catheter body 42. The outer balloon 48 is connected through a lumen in body 42 to a first port 52 in proximal houεing 54 to receive the fluid or semi-solid phase sealant. The inner balloon 50 is connected through a second lumen in catheter body 42 to receive inflation medium through a second port 56 in the proximal hub 54. In this way, a fluid or εe i-εolid sealant may first be delivered to the interior of outer balloon 48 over the inner balloon 50. By then inflating the inner balloon 50, the sealant may be expelled outward through a plurality of fluid delivery ports 58 disposed subεtantially uniformly over the outer cylindrical εurface of the outer balloon 58. Preferably, the outer balloon 58 will be formed from a non-compliant material, εuch as polyethyleneterphthalate. The inner balloon 50 is preferably formed from an elastomeric material, such as silicone rubber latex rubber, or polyurethane. The catheter body 42 is configured to be introduced over a movable guidewire, including guidewire port 60 extending therethrough.
Referring now to Figs. 11A-11F, a method for delivering a vascular prosthesiε according to the preεent invention will be deεcribed. Initially, fluid delivery catheter 40 iε introduced to a region of an aneuryεm A in blood vessel BV over a guidewire GW, as illustrated in Fig. IIA. The outer balloon 48 is then at least partially filled with a fluid or semi-solid sealant S, aε illuεtrated in Fig. 11B. The inner balloon 50 iε then expanded to expel the εealant through the portε 58 into the region of aneurysm A, as illustrated in Fig. IIC.
After sufficient sealant S haε been introduced to the interface region along the inner surface of the blood vessel wall, the catheter 40 will be withdrawn, leaving the sealant S in place, as illustrated in Fig. 11D. A graft delivery catheter 60 may then be introduced to the blood vessel BV so that a tubular prosthesis body 62 is positioned within the sealant S, aε illuεtrated in Fig. HE. As illustrated in Fig. HE, the prosthesiε body 62 is malleable and expanded by an internal balloon 64. It will be appreciated, however, that the prostheεis body 62 could be in the form of a εelf-expanding (reεilient) tube which iε released from radial constraint by a different delivery catheter. Other delivery techniques, such aε axial contraction to cauεe radial expansion of the prostheεis, are also known and could be employed with the present invention. In any case, after the prosthesis body 62 is expanded and/or released, it will compreεε radially outwardly against the sealant material S to compress and conform the sealant into the interface region, as illustrated in Fig. HF. Sealant material may then at least partially harden (optionally by applying energy to cure the material) to provide both for occlusion of the interface region (to prevent bypass flow of blood into the aneurysm A) and also to anchor the prosthesis body 62 in place.
Referring now to Fig. 12, a sealing layer in the form of a bifurcated tube 100 includes a trunk segment 102 and a pair of leg segmentε 104 and 106. Of the εleeve 100 will be composed of a resilient, preferably "spongy" material which can be introduced into the base of the abdominal aorta so that the legs 104 and 106 into the right and left iliac arteries, respectively. Preferably, each of the trunk 102 and right and left legε 104 and 106 will comprise structure, such as a self- expanding spring 108, which will radially expand the sleeve at each of its openings so that the sleeve will self-anchor in the aorta and iliac arteries. Fig. 13 shows an alternative 120 which is generally similar to the sleeve 100, expect that self-expanding tubular elements 122, 124, and 126, are provided in the trunk 128, leg 130, and leg 132 respectively. These self-expanding tubes are generally similar to the tubular prosthesis structures described previously and provide the necessary mechanical support to anchor the sleeve 120 at the bifurcation of the abdominal aorta into the iliac arteries. The sleeve 120, however, will not itself form the necessary vascular graft over the aneurysm, but rather will form a resilient anchor at the base of the aorta for subsequent implantation of a separate vascular graft, as deεcribed in below in connection with Figε 14 and 15. The preferred material for the εleeves 100 and 120 will be micro porous silicone rubber, as described above.
Referring now to Fig. 14, the sleeve 100 or 120 can be implanted at the base of an abdominal aortic aneurysm AAA so that the trunk portion 102 or 128 extends into the aorta and the leg portions 104 or 130 and 106 or 132 extend into the right iliac RI and left iliac LI, respectively. An upper sleeve anchor 140 will be implanted above the aneurysm AAA and below the renal arteries RA. The sleeve 140 will be composed of a similar resilient material, preferably silicone rubber, and will usually be self-expanding so that it can be initially placed at the desired location. A vascular prosthesis P which may be any self-expanding or expandable vascular graft as described previously, may then be implanted between the upper sleeve 140 and base sleeve 100 or 120. In this way, a simple, linear proεthesis can be used to treat an aortic aneurysm AAA. Optionally, additional prosthesis (not shown) could be implanted in each of the legε 104/130 and 106/132 of the sleeve in order the further anchor the sleeve and provide desired support within the iliac arteries.
As an alternative to the upper sleeve 140, a sleeve 150 (Fig. 15) could be provided having εide branches 152 and 154 which extend into the renal arterieε RA. Such a sleeve would be particularly desirable for aneurysms which extend upwardly and approach the renal arteries.
The tubular prostheses of the present invention will also find use in sealing at one or more ends of a previously implanted prosthesis as shown in Fig. 16. There, a prosthesis 200 (which may be a conventional graft or stent or may itself be a "sealing" prosthesiε according to the preεent invention) is initially implanted in an aneurysm A. Over time, the length of the aneuryεm may increaεe, creating pathε at one or both endε for blood to bypasε the prosthesis into the aneurysm. This situation may be corrected by implanting additional sealing prostheεis 202 which are conεtructed in accordance with any of the designs described herein. The prostheεes 202 will be disposed inside each end of the initial or central proεtheεis 200 into the adjacent lumen of the blood vessel. The prostheses 202 are shown to include body 204 and sealing layer 206, and the sealing layer is able to conform to the end transition between the proεtheεiε 200 and the blood vessel wall, providing an effective seal againεt blood bypass and a further anchor of the prostheεis 200 in place. While particularly useful for post-placement sealing, the method of introducing the sealing proεtheses into one or more endε of a primary graft would also be useful at the time the primary graft is first introduced.
An alternative sealing layer construction is shown in Fig. 17. A prosthesis 250 comprises a tubular body 252 and an inner liner 254. The tubular body comprises a plurality of spring-like fingers 256 which support an outer liner 258 radially outward. The inner liner 254 and outer liner 258 may be compoεed of the εame or different materialε, typically being polyester, polytetrafluoroethylene (PTFE) , polyurethane, non-woven fabric, polymeric sheet material or the like.
Generally the liners should present a barrier to blood flow therethrough. The spring-like fingers will allow the outer liner 258 to conform to the inner wall of the blood vessel to provide sealing as described generally above. Figs. 18 and 19 show yet another alternative construction for a sealing layer according to the present invention. The sealing layer compriseε a fabric or 'membrane layer 300 which opens conically about an end 302 of a prosthesis 304. The layer 300 is shown to be supported by a plurality of tines 306 which are connected to the end of the prostheεiε 304. As illustrated, the tines 306 are formed integrally aε part of a metallic framework 310 of the prosthesis, but it will be appreciated that the tines could be welded or otherwise attached to the framework. In the embodiment of Figs. 17 and 18, a fabric liner 316 is shown to be folded from the interior of the prostheεiε back into and over a V-shaped cavity 318 defined by the tines 306. It will be appreciated that, upon deployment in a blood vessel, the layer 300 will engage and conform to the interior surface of the vessel and the layer will seal the end of the prostheεis 304 to inhibit by-pass blood flow. It will be further appreciated that the sealing layer 300 could be formed in a variety of other specific designε, including an unεupported or partially εupported fabric or membrane which iε held open to εeal against the blood vessel wall by the blood flow itself which applies pressure within the cavity 318. Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

Claims

WHAT IS CLAIMED IS;
1. In a method for implanting a tubular prosthesis in a body lumen of the type wherein the tubular prosthesis is expanded in si tu so that an exterior surface of the prosthesis engages an inner wall of the body lumen over an interface region, the improvement comprising expanding the tubular prosthesis, in a sealing layer disposed in at least a portion of the interface region.
2. A method as in claim 1, wherein the tubular prosthesis has at least a first end, a εecond end, and a lumen therebetween, and wherein the εealing layer iε diεpoεed over at leaεt one circumferential band within the interface region.
3. A method aε in claim 2, wherein the sealing layer is disposed within substantially the entire interface region.
4. A method as in claim 1, wherein the tubular prosthesis has a first end and a pair of branched second ends with lumens therebetween, and wherein the sealing layer is disposed over at least a circumferential band within the interface region near the first end.
5. A method as in claim 4, wherein the sealing layer is disposed over substantially the entire interface region.
6. A method as in claim 1, wherein the sealing layer is selected from the group consiεting of gelε, foamε, εpongeε, adheεiveε, biological polymers, microporous meεheε, and a self-expanding mechanical assembly.
7. A method as in claim 6, wherein the sealing layer iε a microporouε εilicone rubber mesh.
8. A method aε in claim 1, wherein the εealing layer iε disposed over at least a portion of the exterior surface of the tubular prosthesis prior to in si tu expansion.
9. A method as in claim 1, wherein the improvement further comprises introducing the sealing layer within the body lumen prior to in si tu expanεion of the tubular proεtheεis.
10. A method for implanting a tubular prosthesis in a body lumen, said method comprising: introducing a εealing layer over an interface region along an interior wall of the body lumen; and expanding a tubular prosthesis within the body lumen so that the sealing layer provides a seal between an exterior εurface of the tubular proεthesis and the interior wall of the body lumen.
11. A method as in claim 10, wherein the sealing layer introducing step compriseε tranεluminally positioning a distal end of a catheter at the interface region within the body lumen and applying a fluid phase sealing material from the distal end of the catheter over said interface region.
12. A method as in claim 11, wherein the fluid phase sealing material is selected from the group consisting of gels, foams, adheεives, and biological polymers.
13. A method as in claim 10, wherein the tubular prostheεis expanding step comprises transluminally positioning a distal end of a catheter near the sealing layer within the body lumen and releasing a radially constrained, self-expanding prosthesis within said sealing layer.
14. A method as in claim 10, wherein the tubular prosthesis expanding step compriseε transluminally positioning a distal end of a catheter near the sealing layer within the body lumen and inflating a balloon on the catheter to expand an at least partially malleable prothesis within said sealing layer.
15. An improved tubular prostheεiε of the type including an expansible tubular frame, wherein the improvement comprises a sealing layer formed over at least a portion of the exterior surface of the tubular frame, said sealing layer being expansible together with the tubular frame and capable of forming a liquid-resiεtant barrier over an annular exterior εegment of the frame after expansion when implanted in a body lumen.
16. An improved tubular prosthesis as in claim 15, wherein the expansible tubular frame is at least partly resilient so that it can be released from radial constraint to assume a large diameter configuration.
17. An improved tubular prosthesis as in claim 15, wherein the expansible tubular frame is at least partly malleable so that it can be radially expanded by application of an internal expansion force.
18. An improved tubular prosthesiε aε in claim 15, wherein the sealing layer is selected from the group conεisting of gels, foams, adhesiveε biological polymers, sponges, compliant sleeveε, microporous meshes, and a self- expanding mechanical aεεembly.
19. An improved tubular prosthesis as in claim 18, wherein the sealing layer is a microporous silicone rubber mesh.
20. An improved tubular prostheεis as in claim 15, wherein the sealing layer is disposed over at least a circumferential band of the exterior surface of the tubular frame.
21. An improved tubular prostheεiε as in claim 20, wherein the sealing layer is disposed over substantially the entire exterior surface.
22. A fluid delivery catheter, said catheter comprising: a catheter body having a proximal and a diεtal end, and at least two lumens extending therebetween; an outer balloon disposed near the distal end of the catheter body and having fluid delivery ports formed therein, said outer balloon being connected to receive a fluid from a first of the lumens; and an inner balloon disposed on the catheter body within the outer balloon and connected to receive an inflation medium from a second of the lumens, wherein expansion of the inner balloon will expel fluid within the outer balloon outwardly through the delivery ports.
23. A fluid delivery catheter as in claim 22, wherein the outer balloon is non-compliant and the inner balloon is elastic.
24. A fluid delivery catheter aε in claim 23, wherein the outer balloon has a generally cylindrical profile when expanded and wherein the delivery ports are substantially uniformly distributed over an outer cylindrical wall thereof.
25. A fluid delivery catheter as in claim 22, wherein the fluid delivery ports have sufficient flow reεiεtance to inhibit fluid flow in the absence of internal pressure provided by the inner balloon.
26. A method for delivering a fluid to an inner wall of a body lumen, said method comprising: poεitioning an outer balloon at a target site within the body lumen; at least partially filling the outer balloon with a fluid material to be delivered; and inflating an inner balloon within the outer balloon to expel the fluid material through fluid delivery ports formed in the outer balloon.
27. A method as in claim 26, wherein the body lumen is a blood vessel and the target site is a location which is to receive a tubular prostheεiε.
28. A method aε in claim 27, wherein the εite is proximate an aneurysm.
29. A method as in claim 26, wherein the outer balloon is filled with a material selected from the group consisting of gels, foams, adhesiveε, and biological polymers.
30. A method aε in claim 29, wherein the outer balloon is filled sufficient to engage its outer surface against an interior wall of the body lumen without substantial loss of fluid material through the delivery ports prior to expansion of the inner balloon.
31. A method as in claim 30, wherein the inner balloon is elastic and is inflated sufficiently to conform to the inner wall of the outer balloon to expel subεtantially all fluid through the delivery ports.
PCT/US1996/014281 1995-09-08 1996-09-06 Method and apparatus for conformably sealing prostheses within body lumens WO1997009008A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU71547/96A AU7154796A (en) 1995-09-08 1996-09-06 Method and apparatus for conformably sealing prostheses within body lumens
DE69633789T DE69633789T2 (en) 1995-09-08 1996-09-06 TUBULAR PROSTHESIS WITH AN IN-SITU EXPANDING AND ADJUSTABLE SEALING LAYER
AT96932961T ATE281129T1 (en) 1995-09-08 1996-09-06 TUBULAR PROSTHESIS WITH AN IN-SITU EXPANDING AND ADAPTABLE SEALING LAYER
EP96932961A EP0857040B1 (en) 1995-09-08 1996-09-06 Tubular prosthesis comprising an in-situ expanding conformable sealing layer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/525,989 US5769882A (en) 1995-09-08 1995-09-08 Methods and apparatus for conformably sealing prostheses within body lumens
US08/525,989 1995-09-08

Publications (1)

Publication Number Publication Date
WO1997009008A1 true WO1997009008A1 (en) 1997-03-13

Family

ID=24095456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/014281 WO1997009008A1 (en) 1995-09-08 1996-09-06 Method and apparatus for conformably sealing prostheses within body lumens

Country Status (6)

Country Link
US (3) US5769882A (en)
EP (1) EP0857040B1 (en)
AT (1) ATE281129T1 (en)
AU (1) AU7154796A (en)
DE (1) DE69633789T2 (en)
WO (1) WO1997009008A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041167A1 (en) * 1997-03-14 1998-09-24 Harry Bernard Joseph Spoelstra Arrangement for the endovascular repair of a blood vessel section
WO1998044873A1 (en) * 1997-04-10 1998-10-15 William Cook, Europe A/S Endovascular graft for repairing abdominal aortic aneurysms
FR2773057A1 (en) 1997-12-29 1999-07-02 Braun Celsa Sa Surgical apparatus for repairing diseased blood vessels, e.g. aneurysm
FR2773058A1 (en) 1998-11-24 1999-07-02 Braun Celsa Sa Surgical apparatus for repairing diseased blood vessels, e.g. aneurysm
WO1999039663A1 (en) * 1998-02-09 1999-08-12 Envatech Corporation Endovascular graft for bridging a defect in a main vessel near one or more branch vessels
WO1999051165A1 (en) * 1998-04-02 1999-10-14 Salviac Limited An implant comprising a support structure and a transition material made of porous plastics material
EP0991357A2 (en) * 1997-06-30 2000-04-12 Eva Corporation Method and apparatus for the surgical repair of aneurysms
US6248116B1 (en) 1997-12-16 2001-06-19 B. Braun Celsa Medical treatment of a diseased anatomical duct
US6312462B1 (en) 1999-09-22 2001-11-06 Impra, Inc. Prosthesis for abdominal aortic aneurysm repair
US6626919B1 (en) 1997-12-29 2003-09-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
US6669707B1 (en) 1998-07-21 2003-12-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
EP1397089A1 (en) * 2001-06-19 2004-03-17 Vortex Innovation Limited Devices for repairing aneurysms
EP1465550A1 (en) * 2001-12-20 2004-10-13 WHITE, Geoffrey H. A device for use in intraluminal grafting
US6827735B2 (en) 2000-03-03 2004-12-07 Cook Incorporated Endovascular device having a stent
WO2007121072A3 (en) * 2006-04-14 2008-02-07 Medtronic Vascular Inc Seal for enhanced stented valve fixation
US7766959B2 (en) 2005-03-25 2010-08-03 Scimed Life Systems, Inc. Variable length endovascular graft prosthesis adapted to prevent endoleaks
EP2753372A4 (en) * 2011-09-09 2015-08-05 Endoluminal Sciences Pty Ltd Means for controlled sealing of endovascular devices

Families Citing this family (333)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6287315B1 (en) * 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
US6042605A (en) 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
EP0950385A3 (en) 1995-12-14 1999-10-27 Prograft Medical, Inc. Stent-graft deployment apparatus and method
ATE290832T1 (en) 1996-01-05 2005-04-15 Medtronic Inc EXPANDABLE ENDOLUMINAL PROSTHESES
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5925074A (en) * 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6352561B1 (en) 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US6030415A (en) * 1997-01-29 2000-02-29 Endovascular Technologies, Inc. Bell-bottom modular stent-graft
CA2235911C (en) * 1997-05-27 2003-07-29 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
US5906641A (en) * 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US5984965A (en) * 1997-08-28 1999-11-16 Urosurge, Inc. Anti-reflux reinforced stent
US5968090A (en) * 1997-09-08 1999-10-19 United States Surgical Corp. Endovascular graft and method
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
WO1999026559A1 (en) * 1997-11-25 1999-06-03 Triad Vascular Systems, Inc. Layered endovascular graft
US6146414A (en) * 1997-12-19 2000-11-14 Gelman; Martin L. Medical graft and construction of the same
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6340368B1 (en) 1998-10-23 2002-01-22 Medtronic Inc. Implantable device with radiopaque ends
US7018401B1 (en) * 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
WO2000044309A2 (en) 1999-02-01 2000-08-03 Board Of Regents, The University Of Texas System Woven bifurcated and trifurcated stents and methods for making the same
US6361557B1 (en) 1999-02-05 2002-03-26 Medtronic Ave, Inc. Staplebutton radiopaque marker
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6620192B1 (en) * 1999-03-16 2003-09-16 Advanced Cardiovascular Systems, Inc. Multilayer stent
US7214229B2 (en) 1999-03-18 2007-05-08 Fossa Medical, Inc. Radially expanding stents
US6709465B2 (en) 1999-03-18 2004-03-23 Fossa Medical, Inc. Radially expanding ureteral device
US6312457B1 (en) * 1999-04-01 2001-11-06 Boston Scientific Corporation Intraluminal lining
US6312421B1 (en) 1999-07-23 2001-11-06 Neurovasx, Inc. Aneurysm embolization material and device
US6309367B1 (en) * 1999-07-23 2001-10-30 Neurovasx, Inc. Aneurysm shield
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US7220276B1 (en) * 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
US6929658B1 (en) 2000-03-09 2005-08-16 Design & Performance-Cyprus Limited Stent with cover connectors
EP1267748B1 (en) * 2000-03-09 2006-06-28 Design & Performance - Cyprus Limited Stent with cover connectors
US6772026B2 (en) * 2000-04-05 2004-08-03 Therics, Inc. System and method for rapidly customizing design, manufacture and/or selection of biomedical devices
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20020049490A1 (en) * 2000-04-11 2002-04-25 Pollock David T. Single-piece endoprosthesis with high expansion ratios
US6517573B1 (en) * 2000-04-11 2003-02-11 Endovascular Technologies, Inc. Hook for attaching to a corporeal lumen and method of manufacturing
US6942691B1 (en) * 2000-04-27 2005-09-13 Timothy A. M. Chuter Modular bifurcated graft for endovascular aneurysm repair
US6729356B1 (en) 2000-04-27 2004-05-04 Endovascular Technologies, Inc. Endovascular graft for providing a seal with vasculature
US20030114918A1 (en) * 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
JP2004506469A (en) 2000-08-18 2004-03-04 アトリテック, インコーポレイテッド Expandable implantable device for filtering blood flow from the atrial appendage
US7229472B2 (en) * 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US6942692B2 (en) * 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
EP1258230A3 (en) 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
ITTO20010465A1 (en) * 2001-05-18 2002-11-18 Sorin Biomedica Cardio Spa MODIFYING STRUCTURE ELEMENT FOR INSTALLATION DEVICES, RELATED INSTALLATION DEVICE AND CONSTRUCTION PROCEDURE.
KR20020094074A (en) * 2001-06-07 2002-12-18 (주)에이치비메디컬스 Implantation tube in the body
US6994722B2 (en) 2001-07-03 2006-02-07 Scimed Life Systems, Inc. Implant having improved fixation to a body lumen and method for implanting the same
US20030014075A1 (en) * 2001-07-16 2003-01-16 Microvention, Inc. Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation
US8252040B2 (en) * 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US8715312B2 (en) * 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) * 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
DE10148185B4 (en) 2001-09-28 2005-08-11 Alveolus, Inc. Instrument for implanting vascular prostheses
US7033389B2 (en) * 2001-10-16 2006-04-25 Scimed Life Systems, Inc. Tubular prosthesis for external agent delivery
GR1004173B (en) * 2001-10-31 2003-02-26 Μεντισπες Ιατροφαρμακευτικων Ειδων Ανωνυμη Εμπορικη Και Βιομηχανικη Εταιρεια Α.Ε.Β.Ε. Metallic stent with arms for the fixation and implantation of biological grafts
US20060292206A1 (en) * 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US20030135266A1 (en) * 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7351255B2 (en) * 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7270668B2 (en) 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7182779B2 (en) * 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7294146B2 (en) * 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US6676624B2 (en) * 2001-12-20 2004-01-13 Scimed Life Systems, Inc. Drainage devices and methods
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
WO2003099108A2 (en) * 2002-05-28 2003-12-04 The Cleveland Clinic Foundation Minimally invasive treatment system for aortic aneurysms
US20030225439A1 (en) * 2002-05-31 2003-12-04 Cook Alonzo D. Implantable product with improved aqueous interface characteristics and method for making and using same
US7044962B2 (en) * 2002-06-25 2006-05-16 Scimed Life Systems, Inc. Implantable prosthesis with displaceable skirt
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guide wire
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
WO2004026183A2 (en) 2002-09-20 2004-04-01 Nellix, Inc. Stent-graft with positioning anchor
US20040098096A1 (en) * 2002-10-22 2004-05-20 The University Of Miami Endograft device to inhibit endoleak and migration
US20040093056A1 (en) * 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7481821B2 (en) * 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20080208160A9 (en) * 2003-01-10 2008-08-28 Mawad Michel E Microcatheter including swellable tip
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7220274B1 (en) * 2003-03-21 2007-05-22 Quinn Stephen F Intravascular stent grafts and methods for deploying the same
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US7452374B2 (en) * 2003-04-24 2008-11-18 Maquet Cardiovascular, Llc AV grafts with rapid post-operative self-sealing capabilities
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
US7241308B2 (en) * 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US7247986B2 (en) * 2003-06-10 2007-07-24 Samsung Sdi. Co., Ltd. Organic electro luminescent display and method for fabricating the same
US20050010138A1 (en) * 2003-07-11 2005-01-13 Mangiardi Eric K. Lumen-measuring devices and method
US20050015140A1 (en) * 2003-07-14 2005-01-20 Debeer Nicholas Encapsulation device and methods of use
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
AU2004263171B2 (en) * 2003-08-07 2008-12-04 Merit Medical Systems, Inc. Therapeutic medical appliance, delivery and method of use
US8721710B2 (en) * 2003-08-11 2014-05-13 Hdh Medical Ltd. Anastomosis system and method
US20050075712A1 (en) * 2003-10-06 2005-04-07 Brian Biancucci Minimally invasive valve replacement system
WO2005034808A1 (en) 2003-10-10 2005-04-21 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US7553324B2 (en) * 2003-10-14 2009-06-30 Xtent, Inc. Fixed stent delivery devices and methods
US7192440B2 (en) * 2003-10-15 2007-03-20 Xtent, Inc. Implantable stent delivery devices and methods
US7403966B2 (en) * 2003-12-08 2008-07-22 Freescale Semiconductor, Inc. Hardware for performing an arithmetic function
US20080109057A1 (en) * 2003-12-10 2008-05-08 Calabria Marie F Multiple point detacher system
US20070104752A1 (en) * 2003-12-10 2007-05-10 Lee Jeffrey A Aneurysm embolization material and device
WO2005058202A1 (en) * 2003-12-17 2005-06-30 Cook Incorporated Interconnected leg extensions for an endoluminal prostehsis
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
CA2553940A1 (en) * 2004-01-30 2005-08-18 Nmt Medical, Inc. Devices, systems, and methods for closure of cardiac openings
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US7674284B2 (en) 2004-03-31 2010-03-09 Cook Incorporated Endoluminal graft
EP1737389B1 (en) * 2004-04-12 2019-07-24 Cook Medical Technologies LLC Stent graft repair device
US20050288766A1 (en) * 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
WO2006012567A2 (en) 2004-07-22 2006-02-02 Nellix, Inc. Methods and systems for endovascular aneurysm treatment
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US20070179600A1 (en) * 2004-10-04 2007-08-02 Gil Vardi Stent graft including expandable cuff
US20060074481A1 (en) * 2004-10-04 2006-04-06 Gil Vardi Graft including expandable cuff
KR100614654B1 (en) * 2005-01-04 2006-08-22 삼성전자주식회사 RF transmitter for efficiently compensating output power variation due to temperature and process
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US7402168B2 (en) * 2005-04-11 2008-07-22 Xtent, Inc. Custom-length stent delivery system with independently operable expansion elements
US20060233990A1 (en) * 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
JP5070373B2 (en) 2005-04-28 2012-11-14 エンドーロジックス インコーポレイテッド Graft system having a filling structure supported by a framework and method of use thereof
US20060247760A1 (en) * 2005-04-29 2006-11-02 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent branch arteries
US7731654B2 (en) 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
US7955372B2 (en) * 2005-06-01 2011-06-07 Board Of Trustees Of The Leland Stanford Junior University Endoluminal delivery system
US20060282149A1 (en) 2005-06-08 2006-12-14 Xtent, Inc., A Delaware Corporation Apparatus and methods for deployment of multiple custom-length prostheses (II)
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US20060282111A1 (en) * 2005-06-09 2006-12-14 Baylor College Of Medicine Segmented Embolectomy Catheter
JP2009500121A (en) 2005-07-07 2009-01-08 ネリックス・インコーポレーテッド System and method for treatment of an intraluminal aneurysm
CA2829353C (en) * 2005-07-27 2016-03-15 Cook Medical Technologies Llc Stent/graft device and method for open surgical placement
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8690957B2 (en) 2005-12-21 2014-04-08 Warsaw Orthopedic, Inc. Bone graft composition, method and implant
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US8900287B2 (en) * 2006-01-13 2014-12-02 Aga Medical Corporation Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm
WO2007097983A2 (en) 2006-02-14 2007-08-30 Sadra Medical, Inc. Systems and methods for delivering a medical implant
CA2646885A1 (en) 2006-03-20 2007-09-27 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
US7481836B2 (en) * 2006-03-30 2009-01-27 Medtronic Vascular, Inc. Prosthesis with coupling zone and methods
US9308105B2 (en) * 2006-04-19 2016-04-12 Cook Medical Technologies Llc Delivery device for an endoluminal prosthesis
US7790273B2 (en) * 2006-05-24 2010-09-07 Nellix, Inc. Material for creating multi-layered films and methods for making the same
US7872068B2 (en) * 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
US8434487B2 (en) 2006-06-22 2013-05-07 Covidien Lp Endotracheal cuff and technique for using the same
US8196584B2 (en) 2006-06-22 2012-06-12 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US20070296125A1 (en) * 2006-06-22 2007-12-27 Joel Colburn Thin cuff for use with medical tubing and method and apparatus for making the same
GB0616738D0 (en) * 2006-08-23 2006-10-04 Evexar Medical Ltd Improvements in and relating to medical devices
US20080053454A1 (en) * 2006-09-01 2008-03-06 Nellcor Puritan Bennett Incorporated Endotracheal tube including a partially inverted cuff collar
US8684175B2 (en) 2006-09-22 2014-04-01 Covidien Lp Method for shipping and protecting an endotracheal tube with an inflated cuff
US8307830B2 (en) 2006-09-29 2012-11-13 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US7950393B2 (en) * 2006-09-29 2011-05-31 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US20080078399A1 (en) 2006-09-29 2008-04-03 O'neil Michael P Self-sizing adjustable endotracheal tube
US20080078401A1 (en) * 2006-09-29 2008-04-03 Nellcor Puritan Bennett Incorporated Self-sizing adjustable endotracheal tube
US8807136B2 (en) * 2006-09-29 2014-08-19 Covidien Lp Self-sizing adjustable endotracheal tube
US20080078405A1 (en) * 2006-09-29 2008-04-03 Crumback Gary L Self-sizing adjustable endotracheal tube
MX344492B (en) 2006-10-22 2016-12-16 Idev Tech Inc * Devices and methods for stent advancement.
EP3034046B1 (en) 2006-10-22 2018-01-17 IDEV Technologies, INC. Methods for securing strand ends and the resulting devices
US20080269774A1 (en) 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US20080188923A1 (en) * 2007-02-01 2008-08-07 Jack Fa-De Chu Endovascular devices to protect aneurysmal wall
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US20080210243A1 (en) * 2007-03-02 2008-09-04 Jessica Clayton Endotracheal cuff and technique for using the same
US20080215034A1 (en) * 2007-03-02 2008-09-04 Jessica Clayton Endotracheal cuff and technique for using the same
CN101715329B (en) 2007-03-05 2012-11-14 恩多斯潘有限公司 Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US20080228259A1 (en) * 2007-03-16 2008-09-18 Jack Fa-De Chu Endovascular devices and methods to protect aneurysmal wall
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20080294237A1 (en) * 2007-04-04 2008-11-27 Jack Fa-De Chu Inflatable devices and methods to protect aneurysmal wall
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
ES2586121T3 (en) 2007-08-21 2016-10-11 Symetis Sa Replacement valve
BRPI0817708A2 (en) 2007-09-26 2017-05-16 St Jude Medical prosthetic heart valve, and lamella structure for the same.
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US9532868B2 (en) 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
EP2194921B1 (en) 2007-10-04 2018-08-29 TriVascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
BRPI0819217B8 (en) 2007-10-25 2021-06-22 Symetis Sa replacement valve for use within a human body, system for replacing a valve within a human body, and heart valve release system with stent
BRPI0819215A2 (en) 2007-10-26 2015-05-05 Cook Critical Care Inc Vascular conductor and delivery system for open surgical placement
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US8750978B2 (en) * 2007-12-31 2014-06-10 Covidien Lp System and sensor for early detection of shock or perfusion failure and technique for using the same
US7862538B2 (en) * 2008-02-04 2011-01-04 Incept Llc Surgical delivery system for medical sealant
JP5417669B2 (en) 2008-02-11 2014-02-19 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Prosthesis coupling device and method
ES2647310T3 (en) 2008-02-22 2017-12-20 Covidien Lp Device for flow restoration
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US20090227976A1 (en) * 2008-03-05 2009-09-10 Calabria Marie F Multiple biocompatible polymeric strand aneurysm embolization system and method
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8974487B2 (en) * 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
AU2009246137B2 (en) * 2008-05-15 2013-10-10 Cook Medical Technologies Llc Systems, devices and methods for accessing a bodily opening
JP2011522615A (en) * 2008-06-04 2011-08-04 ネリックス・インコーポレーテッド Sealing device and method of use
US20090319029A1 (en) * 2008-06-04 2009-12-24 Nellix, Inc. Docking apparatus and methods of use
DK3263070T3 (en) 2008-06-06 2020-01-20 Edwards Lifesciences Corp Low profile transcatheter heart valve
DE202009018961U1 (en) 2008-07-15 2014-11-26 St. Jude Medical, Inc. Heart valve prosthesis and arrangement for delivering a heart valve prosthesis
DE202008009604U1 (en) * 2008-07-17 2008-11-27 Sahl, Harald, Dr. Membrane implant for the treatment of cerebral artery aneurysms
CA2756573A1 (en) 2008-08-19 2010-02-25 Micro Therapeutics, Inc. Detachable tip microcatheter
AU2009296415B2 (en) 2008-09-25 2015-11-19 Advanced Bifurcation Systems Inc. Partially crimped stent
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
ES2409693T3 (en) 2008-10-10 2013-06-27 Sadra Medical, Inc. Medical devices and supply systems to supply medical devices
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
WO2010068793A1 (en) * 2008-12-10 2010-06-17 Microvention, Inc. Microcatheter
US8409606B2 (en) 2009-02-12 2013-04-02 Incept, Llc Drug delivery through hydrogel plugs
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US8590534B2 (en) 2009-06-22 2013-11-26 Covidien Lp Cuff for use with medical tubing and method and apparatus for making the same
EP2445444B1 (en) 2009-06-23 2018-09-26 Endospan Ltd. Vascular prostheses for treating aneurysms
US9327058B2 (en) 2009-07-07 2016-05-03 Cook Medical Technologies Llc Hydrogel enhanced medical devices
CA2767596C (en) 2009-07-09 2015-11-24 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US8118856B2 (en) 2009-07-27 2012-02-21 Endologix, Inc. Stent graft
CA2778944C (en) 2009-11-02 2019-08-20 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
WO2011064782A2 (en) 2009-11-30 2011-06-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
WO2011070576A1 (en) 2009-12-08 2011-06-16 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
CA2785953C (en) 2009-12-31 2016-02-16 Endospan Ltd. Endovascular flow direction indicator
US8906057B2 (en) * 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US20110184509A1 (en) * 2010-01-27 2011-07-28 Abbott Laboratories Dual sheath assembly and method of use
CA2789304C (en) 2010-02-08 2018-01-02 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US20110208292A1 (en) * 2010-02-19 2011-08-25 Abbott Laboratories Hinged sheath assembly and method of use
WO2011119884A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc System and methods for treating a bifurcation
AU2011232361B2 (en) 2010-03-24 2015-05-28 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
CN103037815B (en) 2010-03-24 2015-05-13 高级分支系统股份有限公司 Methods and systems for treating a bifurcation with provisional side branch stenting
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
EP4119107A3 (en) 2010-09-10 2023-02-15 Boston Scientific Limited Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
WO2012051096A1 (en) * 2010-10-11 2012-04-19 Dardi Peter S Hydrogel jacketed stents
US8676319B2 (en) 2010-10-29 2014-03-18 Medtronic, Inc. Implantable medical device with compressible fixation member
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
WO2012071626A1 (en) * 2010-12-01 2012-06-07 Daniel Eduard Kleiner Device for use in endoluminal vacuum therapy
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
CA2826760A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
WO2012116337A1 (en) 2011-02-25 2012-08-30 Microvention, Inc. Reinforced balloon catheter
WO2012117395A1 (en) 2011-03-02 2012-09-07 Endospan Ltd. Reduced-strain extra- vascular ring for treating aortic aneurysm
EP2693980B1 (en) 2011-04-06 2022-07-13 Endologix LLC System for endovascular aneurysm treatment
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
JP2014522263A (en) 2011-05-11 2014-09-04 マイクロベンション インコーポレイテッド Device for occluding a lumen
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9289282B2 (en) 2011-05-31 2016-03-22 Edwards Lifesciences Corporation System and method for treating valve insufficiency or vessel dilatation
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
EP2579811B1 (en) 2011-06-21 2016-03-16 Endospan Ltd Endovascular system with circumferentially-overlapping stent-grafts
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
WO2013030818A2 (en) 2011-08-28 2013-03-07 Endospan Ltd. Stent-grafts with post-deployment variable axial and radial displacement
US9216076B2 (en) 2011-09-09 2015-12-22 Endoluminal Sciences Pty. Ltd. Means for controlled sealing of endovascular devices
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
WO2013084235A2 (en) 2011-12-04 2013-06-13 Endospan Ltd. Branched stent-graft system
MX2014007202A (en) 2011-12-14 2015-03-09 Semprus Biosciences Corp Surface modified contact lenses.
EP2791211A4 (en) 2011-12-14 2015-08-05 Semprus Biosciences Corp Multistep uv process to create surface modified contact lenses
CA2859180A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Surface modification for dialysis catheters
JP2015509114A (en) 2011-12-14 2015-03-26 センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. Absorption method for contact lens surface modification
JP2015507761A (en) 2011-12-14 2015-03-12 センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. Redox method for contact lens modification
EP2791213A4 (en) 2011-12-14 2015-10-28 Semprus Biosciences Corp Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants
US20130274873A1 (en) 2012-03-22 2013-10-17 Symetis Sa Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US20130261660A1 (en) * 2012-04-03 2013-10-03 Warsaw Orthopedic, Inc. Medical devices and methods for inserting an adhesive membrane
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
JP6230166B2 (en) * 2012-06-03 2017-11-15 ダニエル・エデュアード・クレイナー Intraluminal negative pressure therapy device
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US20140350668A1 (en) 2013-03-13 2014-11-27 Symetis Sa Prosthesis Seals and Methods for Sealing an Expandable Prosthesis
JP6533776B2 (en) 2013-03-14 2019-06-19 エンドーロジックス インコーポレイテッド System for treating an aneurysm in a patient's body and method of operating the same
EP3427766B1 (en) * 2013-08-08 2020-09-23 Boston Scientific Scimed, Inc. Dissolvable or degradable adhesive polymer to prevent stent migration
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
WO2015055652A1 (en) 2013-10-14 2015-04-23 Symetis Sa Prosthesis seal
US9913715B2 (en) 2013-11-06 2018-03-13 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak sealing mechanism
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
EP3129097B1 (en) * 2014-04-10 2022-03-02 C. R. Bard, Inc. Ureteral stents
US10154904B2 (en) 2014-04-28 2018-12-18 Edwards Lifesciences Corporation Intravascular introducer devices
US10195025B2 (en) 2014-05-12 2019-02-05 Edwards Lifesciences Corporation Prosthetic heart valve
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10959826B2 (en) 2014-10-16 2021-03-30 Cook Medical Technology LLC Support structure for scalloped grafts
BR112017012425A2 (en) 2014-12-18 2018-01-02 Endospan Ltd endovascular stent graft with fatigue resistant lateral tube
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US9974650B2 (en) 2015-07-14 2018-05-22 Edwards Lifesciences Corporation Prosthetic heart valve
US20170319325A1 (en) * 2015-11-12 2017-11-09 Biostage, Inc. Systems and Methods for Producing Gastrointestinal Tissues at an Anstomosis or Other Physiological Location
US10179043B2 (en) 2016-02-12 2019-01-15 Edwards Lifesciences Corporation Prosthetic heart valve having multi-level sealing member
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
CN109475402A (en) * 2016-06-21 2019-03-15 美敦力瓦斯科尔勒公司 The vascular endoprostheses of coating for aneurysm treatment
CN106214287A (en) * 2016-08-24 2016-12-14 杨威 Dissection of aorta operation overlay film frame, conveyer device and using method
US10813749B2 (en) 2016-12-20 2020-10-27 Edwards Lifesciences Corporation Docking device made with 3D woven fabric
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
WO2018226915A1 (en) 2017-06-08 2018-12-13 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
EP3661458A1 (en) 2017-08-01 2020-06-10 Boston Scientific Scimed, Inc. Medical implant locking mechanism
CN111225633B (en) 2017-08-16 2022-05-31 波士顿科学国际有限公司 Replacement heart valve coaptation assembly
EP3740160A2 (en) 2018-01-19 2020-11-25 Boston Scientific Scimed Inc. Inductance mode deployment sensors for transcatheter valve system
JP7047106B2 (en) 2018-01-19 2022-04-04 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device delivery system with feedback loop
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
WO2019165394A1 (en) 2018-02-26 2019-08-29 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
WO2019222367A1 (en) 2018-05-15 2019-11-21 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
WO2020123486A1 (en) 2018-12-10 2020-06-18 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
CA3133857A1 (en) 2019-03-20 2020-09-24 inQB8 Medical Technologies, LLC Aortic dissection implant
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
EP3875057A1 (en) 2020-03-04 2021-09-08 Michel Marinus Petrus Johannes Reijnen Catheter system for delivery of a filling body to an aneurysmal sac in a body lumen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636213A (en) * 1985-01-24 1987-01-13 Pakiam Anthony I Implantable prosthesis
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890107A (en) * 1972-09-25 1975-06-17 Research Corp Materials useful for prosthetic devices and the like
US3991767A (en) * 1973-11-02 1976-11-16 Cutter Laboratories, Inc. Tubular unit with vessel engaging cuff structure
US4130904A (en) * 1977-06-06 1978-12-26 Thermo Electron Corporation Prosthetic blood conduit
SE424045B (en) * 1979-01-12 1982-06-28 Tesi Ab CATHETER
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4728328A (en) * 1984-10-19 1988-03-01 Research Corporation Cuffed tubular organic prostheses
US4577631A (en) * 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
US5634946A (en) * 1988-08-24 1997-06-03 Focal, Inc. Polymeric endoluminal paving process
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
GB8927282D0 (en) * 1989-12-01 1990-01-31 Univ Strathclyde Vascular surgical devices
US5344426A (en) * 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5092841A (en) * 1990-05-17 1992-03-03 Wayne State University Method for treating an arterial wall injured during angioplasty
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5348788A (en) * 1991-01-30 1994-09-20 Interpore Orthopaedics, Inc. Mesh sheet with microscopic projections and holes
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5628783A (en) * 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
CA2065634C (en) * 1991-04-11 1997-06-03 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
NL9101159A (en) * 1991-07-03 1993-02-01 Industrial Res Bv FORMATTABLE EXPANDABLE RING, CYLINDER OR SLEEVE.
US5167614A (en) * 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5246452A (en) * 1992-04-13 1993-09-21 Impra, Inc. Vascular graft with removable sheath
US5354329A (en) * 1992-04-17 1994-10-11 Whalen Biomedical, Inc. Vascular prosthesis having enhanced compatibility and compliance characteristics
US5368566A (en) * 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
WO1994021320A1 (en) * 1993-03-15 1994-09-29 Advanced Cardiovascular Systems, Inc. Fluid delivery catheter
WO1994021324A1 (en) * 1993-03-23 1994-09-29 Focal, Inc. Apparatus and method for local application of polymeric material to tissue
CA2161776C (en) * 1993-04-28 2005-12-20 Chandrashekhar P. Pathak Apparatus and methods for intraluminal photothermoforming
DE4334140C2 (en) * 1993-10-07 1996-04-18 Angiomed Ag Stent and device with stent
WO1995013033A1 (en) * 1993-11-08 1995-05-18 Lazarus Harrison M Intraluminal vascular graft and method
DE4401227C2 (en) * 1994-01-18 1999-03-18 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5462704A (en) * 1994-04-26 1995-10-31 Industrial Technology Research Institute Method for preparing a porous polyurethane vascular graft prosthesis
US5693085A (en) * 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
DE4418336A1 (en) * 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
DK63894A (en) * 1994-06-06 1996-01-08 Meadox Medicals Inc Stent catheter and method for making such a stent catheter
ES2199993T3 (en) * 1994-06-13 2004-03-01 Endomed, Inc. EXPANSIBLE ENDOVASCULAR GRAFT AND METHOD FOR FORMATION.
ATE296140T1 (en) * 1994-06-27 2005-06-15 Bard Peripheral Vascular Inc RADIALLY EXPANDABLE POLYTETRAFLUORETHYLENE AND EXPANDABLE ENDOVASCULAR STENTS MOLDED THEREFROM
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5562727A (en) * 1994-10-07 1996-10-08 Aeroquip Corporation Intraluminal graft and method for insertion thereof
CA2213403C (en) * 1995-02-22 2007-01-16 Menlo Care, Inc. Covered expanding mesh stent
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5785679A (en) * 1995-07-19 1998-07-28 Endotex Interventional Systems, Inc. Methods and apparatus for treating aneurysms and arterio-venous fistulas
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US5823198A (en) 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636213A (en) * 1985-01-24 1987-01-13 Pakiam Anthony I Implantable prosthesis
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041167A1 (en) * 1997-03-14 1998-09-24 Harry Bernard Joseph Spoelstra Arrangement for the endovascular repair of a blood vessel section
WO1998044873A1 (en) * 1997-04-10 1998-10-15 William Cook, Europe A/S Endovascular graft for repairing abdominal aortic aneurysms
EP0991357A4 (en) * 1997-06-30 2008-05-07 Eva Corp Method and apparatus for the surgical repair of aneurysms
EP0991357A2 (en) * 1997-06-30 2000-04-12 Eva Corporation Method and apparatus for the surgical repair of aneurysms
US6248116B1 (en) 1997-12-16 2001-06-19 B. Braun Celsa Medical treatment of a diseased anatomical duct
US6342059B1 (en) 1997-12-16 2002-01-29 B. Braun Celsa Medical treatment of an affection of an anatomical duct
US6626919B1 (en) 1997-12-29 2003-09-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
FR2773057A1 (en) 1997-12-29 1999-07-02 Braun Celsa Sa Surgical apparatus for repairing diseased blood vessels, e.g. aneurysm
WO1999039663A1 (en) * 1998-02-09 1999-08-12 Envatech Corporation Endovascular graft for bridging a defect in a main vessel near one or more branch vessels
US6395018B1 (en) 1998-02-09 2002-05-28 Wilfrido R. Castaneda Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels
WO1999051165A1 (en) * 1998-04-02 1999-10-14 Salviac Limited An implant comprising a support structure and a transition material made of porous plastics material
US6669707B1 (en) 1998-07-21 2003-12-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
FR2773058A1 (en) 1998-11-24 1999-07-02 Braun Celsa Sa Surgical apparatus for repairing diseased blood vessels, e.g. aneurysm
US6312462B1 (en) 1999-09-22 2001-11-06 Impra, Inc. Prosthesis for abdominal aortic aneurysm repair
US6827735B2 (en) 2000-03-03 2004-12-07 Cook Incorporated Endovascular device having a stent
US8814928B2 (en) 2001-06-19 2014-08-26 Vortex Innovation Limited Apparatus and methods for repairing aneurysms
EP2260795A3 (en) * 2001-06-19 2013-04-17 Novotek Innovation Limited Devices for repairing aneurysms
EP1397089A1 (en) * 2001-06-19 2004-03-17 Vortex Innovation Limited Devices for repairing aneurysms
EP1397089B1 (en) * 2001-06-19 2017-04-19 Endologix, Inc. Devices for repairing aneurysms
US10743979B2 (en) 2001-06-19 2020-08-18 Endologix, Inc. Apparatus and methods for repairing aneurysms
EP1465550A1 (en) * 2001-12-20 2004-10-13 WHITE, Geoffrey H. A device for use in intraluminal grafting
EP1465550B1 (en) * 2001-12-20 2016-03-23 W.L. Gore & Associates, Inc. A device for use in intraluminal grafting
US7766959B2 (en) 2005-03-25 2010-08-03 Scimed Life Systems, Inc. Variable length endovascular graft prosthesis adapted to prevent endoleaks
US8465538B2 (en) 2005-03-25 2013-06-18 Scimed Life Systems, Inc. Variable length endovascular graft prosthesis adapted to prevent endoleaks
WO2007121072A3 (en) * 2006-04-14 2008-02-07 Medtronic Vascular Inc Seal for enhanced stented valve fixation
EP2753372A4 (en) * 2011-09-09 2015-08-05 Endoluminal Sciences Pty Ltd Means for controlled sealing of endovascular devices
CN105232187A (en) * 2011-09-09 2016-01-13 安多拉米诺科学公司 Means for controlled sealing of endovascular devices

Also Published As

Publication number Publication date
DE69633789D1 (en) 2004-12-09
EP0857040A1 (en) 1998-08-12
EP0857040A4 (en) 1999-03-18
US20040098097A1 (en) 2004-05-20
AU7154796A (en) 1997-03-27
US6656214B1 (en) 2003-12-02
ATE281129T1 (en) 2004-11-15
EP0857040B1 (en) 2004-11-03
US5769882A (en) 1998-06-23
DE69633789T2 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
US6656214B1 (en) Methods and apparatus for conformably sealing prostheses within body lumens
US20210361450A1 (en) Graft systems having filling structures supported by scaffolds and methods for their use
US5709713A (en) Radially expansible vascular prosthesis having reversible and other locking structures
CN108601647B (en) Endoluminal prosthetic device with fluid-absorbent component for repairing vascular tissue defects
US11065097B2 (en) Advanced kink-resistant stent graft
JP5676431B2 (en) Apparatus and method for treating an abdominal aortic aneurysm
US20020151958A1 (en) Large vessel stents and occluders
US20090198267A1 (en) Methods and systems for endovascular aneurysm treatment
US20060184238A1 (en) Braided stent to be implanted in a blood vessel
EP1214020A1 (en) Prosthesis for abdominal aortic aneurysm repair
WO1997019653A1 (en) Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
JP2011509104A (en) Thin medical device
EP1558177A2 (en) Endograft device to inhibit endoleak and migration
WO2006116725A2 (en) Graft systems having filling structures supported by scaffolds and methods for their use
US11723668B2 (en) Systems and methods with anchor device for fixation of filling structures in blood vessels

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996932961

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996932961

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1996932961

Country of ref document: EP